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ABSTRACT 
The purpose of this PhD thesis is to perform a dissertation about the equine umbilical cord 
(UC), with particular attention to its macroscopic characteristics moving into its microscopic 
features. Furthermore, equine UC was microscopically and immunohistochemically 
described. The coiling makes the UC a structure both flexible and strong, and provides 
resistance to external forces, which could compromise blood flow. Data obtained from the 
present study could be considered as a normal range of number of coils and UCI in the equine 
physiological pregnancies. The second and major component of this dissertation was focused 
on umbilical cord as a Mesenchymal Stem Cells (MSCs) niche. In particular, the 
ultrastructural characterization and immune profile of equine MSCs derived from foetal 
tissues (Wharton’s jelly and blood) were investigated; equine foetal MSCs were then 
compared to human foetal MSCs and equine adult MSCs. The third section included the 
clinical applications of MSCs derived from AF and WJ on cutaneous wounds of different 
ages’ foals. The employ of foetal MSCs on cutaneous wounds decreased their healing both in 
neonatal foals and six-month foals, in comparison with other traditional treatments. In 
conclusion, one of the most important feature of placenta’s evaluation is the observation of 
normal characteristic of the equine UC. Furthermore, since the UC is a discarded material 
after delivery, it represents an excellent non-invasive alternative source of MSCs with reliable 
migration and differentiation capacities, and it is a convenient cell source for autologous or 
allogeneic regenerative therapies. Finally, it is important a constant update about regenerative 
medicine and the development of research in this field considering that the horse serves as a 
perfect model for humans. 
Key words: equine, umbilical cord, Mesenchymal Stem Cells  
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INTRODUCTION 
The umbilical cord (UC) represents an important connection between mother and fetus and it 
is designed to protect blood flow to the fetus during pregnancy. This particular property is due 
to the UC intervascular stroma, a mucous connective tissue, also called Wharton's jelly (WJ). 
It develops from extraembryonic mesoderm, binds and encases the umbilical vessels, 
protecting them from twisting and compression during pregnancy (Ferguson and Dodson, 
2009). Wharton’s jelly also has angiogenic and metabolic roles for the umbilical circulation. 
Some authors demonstrated that, in humans, an alteration of its composition could be related 
to foetal pathologic conditions (Labarrere et al., 1985; Ghezzi et al., 2001; Kulkarni et al., 
2007). 
The equine umbilical cord, divided into amniotic portion toward foetal side and allantoic 
portion towards placental side, should be attached to the dorsal side at the base of one of the 
horns. It consists of 2 veins and 2 arteries in the allantoic portion, and two arteries and one 
vein in the amniotic portion (Withwell and Jeffcott, 1975; Schlafer, 2004; Pozor, 2016). There 
is a significant variation in the length of UC: a large study on 145 Thoroughbred mares found 
a mean length of 55 cm across a broad range of 32–90 cm (Withwell and Jeffcott, 1975). In 
human medicine, the helical pattern, or coiling of the UC (left spiral, counter clockwise), is 
well studied and several authors have addressed the correlations between abnormal cord 
coiling and adverse pregnancy outcome (Machin et al., 2000; De Laat et al., 2006). The origin 
of the umbilical coiling is still poorly understood: the hypotheses include the foetal activity, 
asymmetric blood flow, foetal hemodynamic forces (Ferguson and Dodson, 2009). The 
coiling makes the umbilical cord a structure both flexible and strong, and provides resistance 
to external forces, which could compromise blood flow. Also in equine species, chirality or 
natural coiling of the vessels is common. Schlafer (2004) reported as normal four to five coils 
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over the length of UC. In human clinical practice, determining the “umbilical coiling index” 
(number of complete coils divided by the length of the cord; average 0.24 coils per 
centimeter) may identify the fetus at risk (van Dijk et al., 2002; Chitra et al., 2012; Ernst et 
al., 2013; Ohno et al., 2016). 
 Mesenchymal stem cells (MSCs), also known as multipotent stromal cells or mesenchymal 
progenitor cells (Dominici et al., 2006) are of increasing interest in the regenerative medicine 
field. They represent a heterogeneous population of highly proliferative cells, with a 
characteristic of self-renewal and in vitro multilineage differentiation capacity (Pittenger et 
al., 1999; Fortier, 2005). They can differentiate into lineages of mesenchymal tissues, such as 
bone, cartilage, adipose tissue (AT), muscles, and tendon (Tuan et al., 2003). Although it was 
originally believed that they participate in tissue homeostasis by replacing damaged or 
senescent cells, it is now postulated that they contribute to healing by playing a trophic role, 
producing cytokines and growth factors (Caplan, 2009). 
Placental tissues and foetal fluids represent a source of cells for regenerative medicine. They 
are readily available and easily procured without invasive procedures. Mesenchymal Stem 
Cells (MSCs) from foetal fluids and adnexa are defined as an intermediate between 
embryonic and adult stem cells, due to the preservation of some characteristics typical of the 
primitive native layers. The UC, as discarded material after delivery, represents an excellent 
alternative non-invasive source of MSCs. In fact, MSCs could be derived from WJ or 
umbilical cord blood (UCB). Other sources of foetal MSCs are amniotic fluid (AF) and 
amniotic membrane (AM). However, for practical reasons, the most common harvest method 
employed clinically is from bone marrow (BM) or adipose tissue (AT), although umbilical 
cord blood banks are rapidly expanding. BM-MSCs are easy to harvest, isolate and expand 
but pneumopericardium is a potential severe, but rarely reported, complication (Durando et 
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al., 2006). AT-MSCs are also easy to harvest but require a more invasive standing surgical 
procedure. AT yields a greater quantity of MSCs per volume without expansion when 
compared to BM, but their osteogenic and chondrogenic differentiation capacity has been 
reported to be lower and they are less studied than BM-MSCs (Vidal et al. 2007, 2008; 
Kisiday et al. 2008; Colleoni et al. 2009). Studies in large animal models are particularly 
important in orthopedic diseases, as regeneration and function of the load-bearing 
musculoskeletal tissues can be assessed best when the size of the anatomical structure and the 
load it is subjected to are of similar dimensions as in humans. Furthermore, the most reliable 
results are obtained when the disease model best possibly reflects the conditions encountered 
in humans (Brehm et al., 2012; Cook et al., 2014). Only recently it has been demonstrated a 
high level of analogy between human and equine cells, providing a reliable basis for 
translational studies on MSC therapies in the equine large animal model (Hillmann et al., 
2016). 
The purpose of this PhD thesis is to perform a dissertation about the equine umbilical cord, 
with particular attention to its macroscopic characteristics moving into its microscopic 
features. 
The first section collects studies about macroscopic and histological features of equine 
umbilical cord; the second one includes studies on equine Mesenchymal Stem Cells derived 
from foetal tissues: their characterization and immunophenotype, their comparison with 
MSCs derived from equine adult tissues and the comparison between equine and human 
foetal MSCs. Finally, the third section includes the clinical application of MSCs derived from 
AF and WJ on cutaneous wounds of foals of different ages.  
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SECTION I-   Studies on equine umbilical cord 
CHAPTER 1 
STUDY OF UMBILICAL CORD IN THE EQUINE SPECIES 
Abstract: Oral presentation  
XXI International SIVE Congress (Società Italiana Veterinari per Equini), February 6
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-8
 th
 
2015, Pisa, Italy  
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MACROSCOPIC CHARACTERISTICS OF THE UMBILICAL CORD IN 
STANDARDBRED, THOROUGHBRED AND SADDLEBRED HORSES 
Article in preparation (Journal: Theriogenology) 
Mariella J.1, Iacono E.1, Lanci A.1, Merlo B.1, Palermo C.3, Morris L.2, Castagnetti C.1 
1
Department of Veterinary Medical Sciences, University of Bologna, via Tolara di Sopra 50, 40064, Ozzano 
Emilia, Bologna, Italy 
2
Equibreed NZ, 99 Parklands Rd, RD 1, Te Awamutu 3879, New Zealand 
3
Practitioner, France 
Introduction 
The umbilical cord (UC) is an important connection between mother and fetus allowing the 
latter to receive oxygen and nutrients necessary for survival and development. The equine UC 
develops from the convergence of the two foetal sacs, the amnion and allantois around the 
remnants of the yolk sac and the vitelline duct to form a cord-like structure by Day 50 
(Whitwell, 1975; Latshaw, 1987). The equine UC division into an intra-amniotic and intra-
allantoic portion was illustrated since 1753 (Steven, 1982). The intra-amniotic portion is 
proximal, covered by amnion and attached to the fetus at the umbilicus; it contains two 
umbilical arteries and one umbilical vein, the urachus, and the vitelline vein remnant 
(Whitwell and Jeffcott 1975; Schlafer, 2004b). The distal intra-allantoic portion is covered by 
the allantois and it is attached to the allantocorion (Whitwell and Jeffcott 1975; Schlafer, 
2004a). In this portion, the two major umbilical arteries become divergent and multibranched 
towards the chorion and the two umbilical veins remain close to these arteries. The two major 
veins unite at the proximal end of the allantoic portion or just inside the amniotic cavity 
(Whitwell and Jeffcott 1975, Schlafer, 2004a). The normal attachment side to the 
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allantochorion is between the two horns (Schlafer, 2004b). The urachus connects the fetal 
urinary bladder to the allantoic cavity within loose stromal tissue in the amniotic portion. 
Few studies described the equine umbilical cord, mainly in the Thoroughbred (Whitwell and 
Jeffcott 1975; Schlafer, 2004a). On the contrary, in human medicine the gross features of the 
UC has been intensively studied and one of its peculiar characteristics, the helical structure, 
focused the attention of bioengineers and physical scientists (Ferguson and Dodson, 2009). 
Strong et al., (1994) devised an Umbilical Coiling Index (UCI) calculated by dividing the 
total number of umbilical coils by the umbilical cord length (cm) for use during 
ultrasonographic assessment of the UC. In more recent studies (Chitra et al., 2012; Ohno et 
al., 2016) found that the UCI is an effective indicator of perinatal outcome. A hypocoiled cord 
was strongly associated with preeclampsia in woman (Chitra et al., 2012; Ezimokahai et al., 
2001). 
Machin et al., (2000) reported frequency and clinical correlations of abnormally coiled cords 
in 1329 newborn. Principal clinical correlations found in ipercoiled and hypocoiled cords 
were foetal demise, foetal intolerance to labor, intrauterine growth retardation, and 
chorioamnionitis. Abnormal cord coiling was associated with thrombosis of chorionic plate 
vessels, umbilical venous thrombosis, and cord stenosis. The authors concluded that an 
abnormal cord coiling is a chronic state, established in early gestation, that may have chronic 
(growth retardation) and acute (foetal intolerance to labor and foetal demise) effects on foetal 
well-being. The cause of abnormal cord coiling is until now unknown. In human medicine, an 
antenatal detection of abnormal UCI by ultrasound could lead to elective delivery of fetuses at 
risk, thereby reducing the foetal death rate and it is recommend that the UCI become part of 
the routine placental pathology examination. 
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In equine reproductive medicine, despite the macroscopic examination of the placenta after 
delivery is a fundamental feature of post-partum examination, the UCI has never been 
investigated. 
The present study aimed to describe the macroscopic features of equine umbilical cord, such 
as length and number of coils of each portion, to calculate the umbilical coiling index in 
normal pregnancy and healthy foals. These features were compared between three different 
breeds and in relation to the foal’s gender. This study also aimed to verify if there is a 
correlation between the macroscopic UC characteristics and mare and perinatal features. 
Materials and Methods 
Animals and data collection 
One hundred twenty four healthy mares with normal pregnancy were enrolled in the study. 
Eighty/124 were housed for attending delivery at the Equine Perinatology Unit (EPU) 
“Stefano Belluzzi” - Department of Veterinary Medical Sciences - University of Bologna, 
during six breeding seasons (2011-2016); 44/124 were housed at EquiBreed - New Zealand, 
during the breeding season 2013. The mares were divided into three groups according to the 
breed: 70 Standardbreds (STB), 38 Thoroughbreds (THB) and 16 Saddlebreds (SAD). 
Information about mare’s age and parity were recorded at admission. At delivery, the 
following data were registered: length of pregnancy, placental weight, presence of foetal 
membranes alterations, UC length and number of coils of both portions. The Umbilical 
Coiling Index (UCI), which is the ratio between total coils and total UC length, was then 
determined. Placental weight was measured weighing the entire placenta along with the 
amnion and umbilical cord, as suggested by Elliott et al., 2009. Furthermore, immediately 
after foaling, APGAR score (Vaala, 2006), foal’s weight and sex were recorded. Only healthy 
mares with normal delivery and healthy foal were enrolled. The foals were classified as 
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healthy when they had a normal clinical evaluation during the course of hospitalization, 
including a complete blood count and serum biochemistry at birth and an IgG serum 
concentration ≥800 mg/dL at 18 h of life. 
Statistical analysis 
All parameters were tested for normal distribution by using Kolmogorov–Smirnov test. 
Because the data showed non normal distribution, the variables were analyzed with 
nonparametric methods. Spearman's rank correlation coefficients were used to test the 
hypothesis that the anatomical features of the UC and the descriptive data related to mares 
and foals were correlated. 
Kruskal–Wallis test was performed to compare anatomical characteristics of the UC, placental 
weight and data relative to foals and mares between the 3 groups. When a statistically 
significant difference was found, the Bonferroni post-hoc procedure for all pair-wise 
comparisons was applied. To tests the hypothesis that anatomical features of the UC, 
placental and foal’s weight were related to foal’s gender, the Wilcoxon’s test was performed. 
The Mann-Whitney test was used to compare the length of the allantoic and amniotic portion 
of the cord in each breed. 
Descriptive statistics, including mean ± SD and range (min/max values) were calculated. A P 
value less than 0.05 was considered statistically significant. All analyses were carried out 
using the commercial software Analyse-it, version 2.03 (Analyse-it Software Ltd., Leeds, 
West Yorkshire, England). 
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Results 
Data were collected in the three different breeds and significant differences are reported in 
Table 1.1. 
Correlations were investigated within each breed. In STB, the mare’s age was correlated with 
parity (P <0.0001; rs =0.80) and foal’s weight at birth (P = 0.034; rs = 0.26); the foal’s weight 
was correlated with parity (P = 0.037; rs = 0.26), gestational length (P = 0.030; rs = 0.27), 
placental weight (P <0.0001; rs = 0.59) and UC allantoic length (P = 0.013; rs = -0.32). 
Gestational length was correlated with placental weight (P = 0.025; rs = 0.28). 
In THB, the gestational length was correlated with placental weight (P = 0.012, rs = - 0.42), 
the foal’s weight was correlated with placental weight (P <0.0001, rs = 0.59). No other 
correlations were found. 
In SAD, mare’s age was correlated with allantoic length (P = 0.03; rs = 0.56); gestational 
length was correlated with placental weight (P = 0.025; rs = -0.54); foal’s weight at birth was 
correlated with placental weight (P = 0.005; rs = 0.69), number of total coils (P = 0.04; rs = 
0.60), and allantoic coils (P = 0.002; rs = 0.74). 
About the UC, in each breed, total length was correlated with number of total coils; UC’s 
amniotic length was correlated with the number of amniotic coils as the allantoic length with 
the number of allantoic coils. The UCI was similar in all breeds: in STB was 0.09 ± 0.03, in 
THB was 0.09 ± 0.02 and in SAD was 0.1 ± 0.03. 
The significant gender-based differences within each breed are summarized in Table 1.2. 
  
S E C T I O N  I - S t u d i e s  o n  e q u i n e  u m b i l i c a l  c o r d | 16 
 
 
Figure 1.1. Amniotic coils at the end of the stage II labour in STB mares (a, b, c, d). There is more 
coils in a, b, than in c, d. 
 
Figure 1.2. Amniotic portion (am) and allantoic portion (al) with coils. 
  
am 
al 
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Table 1.1. Data collected in the three different breeds. Continuous variables are expressed as mean ± 
SD and minimum and maximum value (range). Different letters in rows indicate significant differences 
(*P < 0.05, #P < 0.001and $P < 0.0001, respectively) between groups. 
 
Table 1.2. Significant gender-based differences within breeds. Continuous variables are expressed as 
mean ± SD and minimum and maximum value (range). 
  
 
STB (n=70) THB (n=38) SAD (n=16) 
Mare's age (y) 
10.1 ± 4.5 
a
 
(4-22) 
8.4 ± 2.8 
a
 
(4-16) 
16.3 ± 4.1 
b$
 
(7-24) 
Parity (n) 
4 ± 3 
(1-13) 
3 ± 1 
(1-6) 
2 ± 1 
(1-3) 
Gestational length (d) 
343 ± 14 
a*
 
(322-389) 
352 ± 16 
b 
(330-396) 
344 ± 14 
ab 
(320-363) 
Foal's sex 
27 M 
43 F 
18 M 
20 F 
7 M 
9 F 
Foal's weight (kg) 
49.1 ± 9.4 
a
 
(31-64) 
65 ± 8.7 
b$
 
(48-85) 
48.5 ± 8.3 
a 
(27-59) 
Placenta's weight (kg) 
5.5 ± 1.3 
a
 
(2.8-6.3) 
6.6 ± 1.1 
b$ 
(4-8) 
4.8 ± 0.4 
a 
(4.5-5) 
UC total length (cm) 
56 ± 12.5 
(37-95) 
56.1 ± 10.6 
(34-81) 
60.3 ± 18.2 
(34-100) 
UC total coils(n) 5 ± 1  5 ± 1  6 ± 1  
UC allantoic length (cm) 
25.8 ± 8.9 
(11-53) 
22.9 ± 6.9 
(10-42) 
29.9 ± 12.5 
(12-53) 
UC allantoic coils (n) 2 ± 1 2 ± 1 3 ± 1 
UC amniotic length (cm) 
30.1 ± 8.2 
a*
 
(18-60) 
33.2 ± 7.4 
b
 
(16-51) 
30.3 ± 13.2 
ab 
(15-65) 
UC amniotic coils (n) 3 ± 1 3 ± 1 3 ± 1 
UCI 0.09 ± 0.03  0.09 ± 0.02 0.1 ± 0.03 
 
Male Female Breed, P value 
Foal's weight (kg) 
68.1 ± 7.7 
(56-85) 
62.3 ±8.9 
(50-79) 
THB, P = 0.03 
Placenta's weight (kg) 
6.9 ± 1.2 
(4-8) 
6.2 ± 1 
(4.6-7.3) 
THB, P = 0.03 
UC total length (cm) 
60.3 ± 11.6 
(37-85) 
53.1 ± 12.4 
(37-95) 
STB, P = 0.008 
UC allantoic length (cm) 
29.3 ± 9.9 
(14-53) 
23.5 ± 7.5 
(11-42) 
STB, P = 0.03 
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Discussion 
Many authors described the characteristics of the normal equine placenta but only few data 
were provided on the umbilical cord. Most of them are related to Thoroughbreds or to mixed 
group of breeds. To our knowledge, there are no studies that compare placenta and UC 
features between equine breeds. 
In the present study, emerged that mare’s age was higher in SAD than in THB and STB. This 
probably reflects the different attitude and management of the breeds: STB and THB begin 
their reproductive career early, while SAD begin the agonistic activity when they are older 
than THB and STB. Only in STB, mare’s age was correlated with parity. This probably 
reflects the stud farm management that caused an increased use of the mare for reproduction 
purpose and less use of reproductive biotechnologies. 
As recently reported (Rosales et al., 2017), normal gestational length in THB ranged between 
330 and 396 days, with a mean of 352 In the mare, gestational length is influenced by 
daylight (Hodge et al., 1982; Sharp, 1988). All THB included in the present study were 
housed near Auckland, New Zealand, where the hour of daylight ranged from 11.20 to 14.30, 
while in Bologna, Italy, daylight ranged from 11 to 15.25 
(http://www.timeanddate.com/sun/new-zealand/auckland). This is probably the reason 
because STB, all housed in Italy, had a lower gestational length than THB; it is worth noting 
that the STB gestational length reported in the present study is comparable to THB gestational 
length reported in studies from the United Kingdom (Davies Morel et al., 2002). 
As regard the foal weight, it was correlated with the placental weight in all breeds. Normal 
placental weight at term is approximately 11% of the foal weight (Pascoe and Knottenbelt, 
2003; Schlafer, 2004), as further confirmed in the present study. Only in THB, foal’s weight 
and subsequently the placental weight is higher in colt than in filly and probably this is due to 
a more pronounced sexual dimorphism as reported by Hintz et al (1979). It is worth noting 
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that in STB, which had a higher number of foaling than the other breeds, foal’s weight was 
related to parity and gestational length. The hypothesis suggested by Elliott et al. (2009) and 
Wilsher and Allen (2002, 2003) is that the equine uterus needs to be in some way primed by a 
first pregnancy before it can achieve its full potential in terms of facilitating foetal growth. 
Wilsher and Allen (2003) suggested that the primiparous placentas have reduced 
microcotiledon surface densities coupled with reduced corionic volumes resulting in less total 
available area for haemotrophic exchange of nutrients and gases. 
The correlation between gestational length and foal’s weight is not in accordance with the 
current knowledge about the equine pregnancy length. Foals born after a prolonged pregnancy 
are defined postmature and they usually show weak suckle reflex, poor thermoregulation and 
glucose regulation, poor postural reflexes, fully erupted incisors and are thin with poor muscle 
development (Palmer, 1998). Since the gestational length ranges reported in the present study 
in healthy mares with healthy foals are particularly wide, in the authors’ opinion, it is difficult 
to define what a prolonged pregnancy is in the equine species. Also Palmer (1998) reported 
that normal gestational length may vary from 315 days to more than 390 days. 
As regard the mean total UC length, data reported in the present study are comparable to the 
previous reported in Thoroughbred (Whitwell and Jeffcott, 1975; Whitehead et al., 2003), 
Standardbred (Oulton et al., 2003), and Warmblood (Govaere et al., 2014). What is surprising 
from the data is the wide range of length and that the human UC has the same length of the 
equine one. A preliminary study in infants with a short umbilical cord showed that they had 
lower tibia speed of sound (SOS) measurements compared with infants with a longer cord. 
The authors postulated that this difference might be due to the restricted activity of the fetus 
with the short cord (Wright and Chan, 2009). In human newborns, decreased foetal 
movements and activity have been associated with decreased infant bone mineralization 
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(Miller, 2005). This field of research was never been investigated in the equine neonates. 
From the first studies in the 60’s in human medicine, it is known that the cord’s length is not 
correlated to maternal and foetal factors such as parity, age, weight, sex and presentation and 
that there is little growth of the cord during the last trimester (Walker and Pye, 1960). Also 
Malpas (1964) found no correlation of cord length with placental or birth weight. Miller et al. 
(1981) noted that cord length was related to the stretching placed on the cord by the 
developing embryo and fetus; the tension is determined by the availability of intrauterine 
space and the occurrence of foetal movement. In a more recent study (Sheiner et al., 2004), 
the authors found that cord problems such as true cord knots and nuchal cords were 
significantly associated with male gender; they hypothesized that it is due to the longer cords 
and suggested that further studies should investigate umbilical cord length differences 
between male and female fetuses. Also in veterinary medicine, this aspect has never been 
investigated. The length of the two portions of the cord is statistically different in STB and 
THB, where the amniotic portion is longer than the allantoic one. The amniotic portion is 
longer in THB than in STB, probably because of the higher foetal weight. In the present 
study, only in STB the length of the UC and the allantoic portion are longer in colt than in 
filly. Since there is not weight difference between male and female in STB, the hypothesis is 
that the difference in the allantoic length could be due to other factors as described in human 
medicine. We can speculate that the amniotic portion is longer than the allantoic because is 
more affected by the stretching during the foetal movement. In human medicine, the helical 
pattern, or coiling, of the umbilical cord is well studied and several studies have addressed the 
correlations between abnormal cord coiling and adverse pregnancy outcome (Machin et al., 
2000; de Laat et al., 2006). The origin of the umbilical coiling is still poorly understood: the 
hypotheses include foetal activity, asymmetric blood flow, foetal and hemodynamic forces 
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(Ferguson and Dodson, 2009). The umbilical coil is defined as one complete spiral of 360° of 
the umbilical vessels around each other. The coiling makes the umbilical cord a structure both 
flexible and strong, and provides resistance to external forces which could compromise blood 
flow. To the authors knowledge, the number of coils and the UCI was never been investigated 
in veterinary medicine. In the equine species, this is the first study that investigated these 
features and it seems that the number of the coils (total, allantoic and amniotic coils) is the 
same in each breed studied. Only in SAD, there is a positive correlation with the foals’ weight 
at birth and it cannot be excluded that the foetal weight is one of the item that contribute to 
the origin of the umbilical coiling. Data obtained from the present study could be considered 
as a normal range of number of coils and UCI in the equine physiological pregnancies. 
Currently, there are no data about the correlation between the number of coils and the adverse 
pregnancy outcome in the equine, whereas in human medicine it is well known: undercoiling 
may give way to kinking and compression, whereas overcoiling may give way to occlusion. 
This may help to explain the association with low Apgar Score in undercoiled cords and with 
low arterial pH and asphyxia with overcoiled cords (Machin et al., 2000; de Laat et al., 2006). 
What is worth noting is that it is the normal characteristic of the equine umbilical cord and 
that it should be considered during the evaluation of equine placenta immediately after foaling 
and placental expulsion, as it is well known by the equine specialist (Pozor, 2016). 
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CHAPTER 2 
MICROSCOPIC CHARACTERISTICS OF THE UMBILICAL CORD IN 
THE EQUINE SPECIES 
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Introduction 
The umbilical cord (UC) is an important connection between mother and fetus and is designed 
to protect blood flow to the fetus during pregnancy (Ferguson and Dodson, 2009). In human 
medicine, the microscopic aspects of the UC has been intensively studied, whereas in equine 
medicine, only few studies described UC microscopically. Both human and equine umbilical 
cords are composed of a vascular component and a gelatinous substance, Wharton’s jelly 
(WJ). This is made of fibroblasts, collagen fibres and an amorphous ground substance 
composed mainly of hyaluronic acid (Schoenberg et al., 1960; Takechi et al., 1993; Franc et 
al., 1998). 
In a recent study, Kumar et al. (2013) described gross anatomy and microscopic features at 
different sites of six normal equine UCs. However, the Wharton’s jelly of healthy and ill foals 
was never microscopically investigated. 
The aim of this preliminary study was to describe the equine umbilical cord microscopically 
and immunohistochemically. 
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Materials and Methods 
Animals and UC sampling 
Twenty-eight mares housed for attended delivery at the Equine Perinatology Unit of 
University of Bologna, during two breeding seasons (2014-2015) were included in the study. 
The mares were hospitalized at about 310 days of pregnancy because the owners requested an 
attended parturition, and remained under observation for at least 7 days postpartum. They 
were housed in wide straw bedding boxes and fed with hay ad libitum and concentrates twice 
a day. During the day, the mares were allowed to go to pasture. At admission, a complete 
clinical evaluation, including complete blood count, serum biochemistry and transrectal 
ultrasonography, was performed. During hospitalization, mares were clinically evaluated 
twice a day and by transrectal ultrasonography every 10 days, until parturition. Information 
about mare’s age and parity were recorded at admission. At delivery, the following data were 
recorded: gestational length, days of pregnancy, length of stage II labour (minutes), placental 
weight and presence of foetal membranes alterations. Macroscopic evaluation of umbilical 
cords was performed to identify any abnormality and for the evaluation of WJ’s distribution. 
Furthermore, immediately after foaling, APGAR score within 5 min from birth (Vaala, 2006), 
foal’s weight, sex and outcome were recorded. For microscopic evaluation, immediately after 
breaking the umbilical cord, the UC intramniotic portion closest to the foal (about 15 cm), 
characterized by a more amount of WJ, was collected. 
All the mares were healthy and delivered healthy foals after a normal pregnancy. The foals 
were classified as healthy when they had an Apgar score ≥8 and a normal clinical evaluation 
during the course of hospitalization, including a complete blood count and serum 
biochemistry at birth and an immunoglobulin G (IgG) serum concentration ≥800 mg/dL at 18 
hs of life. 
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Wharton’s jelly weight 
At the Laboratory of Biotechnology and Animal Reproduction (LRBA) of the Department of 
Veterinary Medical Sciences (DIMEVET), UCs were disinfected by immersion in ethanol 
70% for 10 minutes, and then they were rinsed by repeated immersion in DPBS, under a 
laminar flow hood. For each UC, Wharton's jelly was isolated and weighed. 
Microscopic and immunohistochemical analysis 
At the Laboratory of Normal Anatomy (LNA), after rinsing in PBS (pH 7.4) for 12 hours at 
4°C, samples were stored in a PBS solution containing 0.1% sodium-azide, and 30% sucrose 
solution and they were stored at 4°C. 
Microscopic description 
Ten sections of 15 μm for each sample were obtained at the cryostat and they were 
mounted in gelatin-coated glass slides. Umbilical cord’s sections were stained with 
Masson’s trichrome stain. For an accurate analysis of WJ the section were stained also 
with Orcein technique to identify elastic fibres and with Silver Impregnation technique to 
identify reticular fibres. 
Immunohistochemical analysis of WJ 
The immunohistochemical analysis was conducted giving particular attention at WJ. 
After three washings for 10 mins in PBS, sections were incubated with 1% H2O2 in PBS 
for 30 mins at room temperature to eliminate endogenous peroxidase activity. Sections 
were rinsed in PBS three times for 10 mins and incubated in a solution containing 10% 
normal goat serum (Colorado Serum, Denver, CO, #CS 0922) and 0.5% Triton X-100 
(Merck, Darmstadt) in PBS for 2 hours at room temperature. Thereafter, the sections of 
each sample were incubated for 48 hours at 4°C in a solution containing: 
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 Rabbit anti-bovine collagen type I polyclonal antibody dilution 1:80 (Chemicon, 
Temecula, CA-USA, lotto NG1804950); 
 Rabbit anti-human collagen type V polyclonal antibody dilution 1:40 (Chemicon, 
Temecula, CA-USA, lotto 0604027824); 
 Rabbit anti-collagen type VI polyclonal antibody dilution 1:10-1:40 (Chemicon, 
Temecula, CA-USA, lotto NG 1833210); 
 Anti-fibrillin clone 689 purified mouse monoclonal antibody dilution 1:200 
(Chemicon, Temecula, CA-USA, lotto NRG1758239). 
The primary antibody was diluted in a solution (1.8% NaCl in 0.01 M PBS containing 
0.1% sodium azide) containing 1% normal goat serum and 0.5% Triton X-100. After 
three washing in PBS, the sections were incubated in goat biotinylated anti- rabbit 
10µg/ml (Vector Laboratories, Burlingame, CA, USA, BA-1000) or goat biotinylated 
anti- mouse 10µg/ml (Vector Laboratories, Burlingame, CA, USA, BA-9200) for 2 
hours at room temperature. The secondary antibody was diluted in PBS containing 1% 
normal goat serum and 0.5% Triton X-100. The sections were transferred to avidin–
biotin complex (ABC kit Vectastain, PK-6100, Vector Laboratories, Burlingame, CA) 
for 30 min and the immunoperoxidase reaction was developed by 3,30-
diaminobenzidine (DAB kit, SK-4100, Vector Laboratories, Burlingame, CA). Slides 
were dried overnight, dehydrated in ethanol, cleared in xylene, and coverslipped with 
Entellan (Merck, Darmstaldt, Germany). All the incubations were performed in a humid 
chamber. Masson trichrome staining was also performed to better highlight the 
fibroblasts. The Orcein Technique and the Silver Impregnation Technique were 
performed. 
S E C T I O N  I - S t u d i e s  o n  e q u i n e  u m b i l i c a l  c o r d | 33 
 
Sections were observed with a Zeiss Axioplan microscope (Carl Zeiss, Oberkochen, 
Germany). Images were recorded by using a Polaroid DMC digital photocamera 
(Polaroid Corporation, Cambrige, MA, USA) and DMC 2 software. 
 
Statistical analysis 
Data were analysed for normality using a Shapiro-Wilk test. Pearson’s test was performed to 
compare weight of WJ and data relative to foals and mares. 
Data are expressed as mean ± SD. All analyses were carried out using the software IBM SPSS 
Statistics 23 (IBM Corporation, Milan, Italy). Significance was assessed for P<0.05. 
 
Results 
Information about mares, foals and weight of WJ were reported in Table 2.1. 
The WJ was found just in the intramniotic portion of UC, closest to the foal, while it was 
absent in the allantoic portion (Figure 2.1 and Figure 2.2).  
Mare's age (years) 11 ± 5 
Parity 3 ± 3 
Gestational length (days) 340 ± 8 
Foal's weight (kg) 48.7 ± 13.8 
Foal's sex 14M; 14 F 
WJ (g) 5.1 ± 3.2 
Table 2.1. Information about mares, foals and weight of WJ. 
The amount of WJ (g) was negatively correlated with the mare’s age (P< 0.05; r= - 0.387). No 
others correlations were found. 
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Figure 2.1. Allantoic portion of UC: absence of WJ (a); amniotic portion (b) with WJ (white arrow). 
 
 
 
 
 
 
 
 
 
 
Microscopic description 
All the vessels (two umbilical arteries and one umbilical vein) showed the three typical layers: 
tunica intima, tunica media and tunica adventitia (Figure 2.5). The endothelium of tunica 
intima was regular and well developed having a single layer of cells (Figure 2.3) resting on a 
basement membrane. The subendothelial layer was composed of connective tissue with some 
smooth muscle fibres between the collagen fibres (Figure 2.3, 2.4). The tunica media was 
thicker than tunica intima and it had multiple concentric smooth muscle and few collagen 
fibres (Figure 2.4, 2.5). The tunica adventitia was the thickest layer and the collagen fibres 
Figure 2.2. Equine intramniotic portion of UC with Wharton’s jelly (white arrow). 
a 
b 
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progressively increased going towards the periphery, while smooth muscle fibres decreased 
(Figure 2.5, 2.6). A perivascular tissue, composed by dense collagen fibres arranged 
concentrically, surrounded the tunica adventitia (Figure 2.6, 2.7). This tight tissue was 
composed by dense and well organized connective tissue. On the contrary, the Wharton’s 
jelly was made of loose connective tissue: collagen fibres were arranged to create a loose 
reticular texture (Figure 2.6, 2.8 and 2.9). Other cells observed in WJ were fibroblasts (Figure 
2.8e) and white blood cells (Figure 2.9). Finally, the UC were externally surrounded by 
amniotic membrane (Figure 2.6, 2.7), composed by two thin layers: amniotic epithelium and 
subamnion, an amniotic connective tissue with collagen fibres and fibroblasts (Figure 2.7 
insert). 
The Orcein staining showed the absence of elastic fibres in the Wharton’s jelly. They were 
less concentrated with an uneven pattern around the vessels (Figure 2.10). 
Finally, the silver impregnation staining revealed a dense network of reticular fibres in the 
entire section of the cord (Figure 2.11). 
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Figure 2.3. Tunica intima (TI) at 10x magnification, Masson’s trichrome stain. The endothelium of 
tunica intima (blue arrow). 
 
Figure 2.4. Tunica intima (TI), Tunica media (TM) is included between purple asterisks and tunica 
adventitia (TA). Magnification 5x and Masson’s trichrome stain. 
S E C T I O N  I - S t u d i e s  o n  e q u i n e  u m b i l i c a l  c o r d | 37 
 
 
Figure 2.5. Umbilical vessel with the three layers: tunica intima (TI, white arrow), tunica media (TM, 
purple arrow), tunica adventitia (TM, blue arrow) and perivascular tissue (pt, orange arrow). 
Masson’s trichrome stain. 
 
Figure 2.6. Umbilical section: tunica adventitia (TA), perivascular tissue (pt), Wharton’s jelly (WJ) 
and amniotic membrane (am). Masson’s trichrome stain. 
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Figure 2.7. Umbilical section: tunica adventitia (TA), perivascular tissue (pt) and amniotic membrane 
(am). A particular of amniotic membrane is shown in the insert: it is composed by amniotic epithelium 
(included between red asterisks) and subamnion (included between yellow asterisks). Wharton’s jelly 
is not present in this section. Masson’s trichrome stain. 
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Figure 2.8. These photos represent contiguous sections of Wharton’s jelly performed with Masson’s 
trichrome at different magnifications (a. b. 10x; c. d. 20x; e. f. 40x). Elongated shape and cellular 
prolongations characterize fibroblasts. f. a section of capillary in WJ. 
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Figure 2.9. A particular of WJ: it contains white blood cells (blue asterisks). 
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Figure 2.10. Orcein staining. Presence of uneven and less concentrated elastic fibres (black arrows). 
 
Figure 2.11. Silver impregnation. Presence of a dense network of reticular fibres. 
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Immunohystochemical analysis of WJ 
The immunohistochemical analysis revealed the presence of fibroblast cells positive for 
antibodies anti-type I, V and VI collagen and anti-fibrillin (Figure 4.12). 
 
Figure 2.12. Immunohistochemical analysis at magnification 10x. The photos showed fibroblast 
reactive and positive to fibrillin (a), collagen type I (b), collagen type V (c) and collagen type VI (d).  
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Discussion 
Wharton’s jelly is fundamental for the well-being of the fetus because binds the umbilical 
vessels, protecting them from twisting and compression during pregnancy and delivery 
(Ferguson and Dodson. 2009). In human medicine, WJ is a well-defined structure: it is 
composed of collagen fibres, forming a network of interconnected cavities. The ground 
substance of the jelly is mainly composed by hyaluronic acid and proteoglycans dissolved in 
an aqueous solution of salts, metabolites and plasma proteins (Klein and Meyer 1983; Vizza 
et al., 1996; Ghezzi et al., 2001). 
In the present study, we investigated the microscopic features of umbilical cords collected at 
delivery of healthy foals born from healthy mares after normal pregnancy. The microscopic 
description focused on the analysis of Wharton’s jelly, a still poorly known tissue in the 
equine species. For the first time in equine medicine, we reported the physiological amount of 
Wharton’s jelly in normal umbilical cord. In human medicine, in fact, a quantitative variation 
of WJ was associated with pathological conditions such as hypertensive disorders (Bankowski 
et al., 1996), foetal distress (Goodlin, 1987), gestational diabetes (Weissman and Jakobi, 
1997) and foetal growth restriction (Bruch et al., 1997; Ghezzi et al., 2001; Ghezzi et al., 
2004). Furthermore, the total absence of WJ has been associated with foetal death (Kulkarni 
et al., 2007). The reduction of WJ facilitates torsion, compression or stretching of UC that 
would adversely affect foetal blood flow (Ferguson and Dodson, 2009; Kurita et al., 2009). 
Moreover, Goodlin (1987) reported that male fetus had more WJ, but with connective more 
loose; then male and female fetuses had the same density of WJ. We found that the amount of 
WJ at term was negatively correlated with the mare’s age. No differences were found in the 
amount of WJ between colts and fillies. 
Furthermore, in human medicine, different authors measured the amount of WJ during 
pregnancy. Raio et al. (1999) reported that quantitative WJ variations occurred in normal 
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pregnancies: they measured ultrasonographically the Area of WJ (WJA) and reported that 
WJA increased up to 32 weeks of gestation and then remained at this plateau until the end of 
pregnancy. Ghezzi et al. (2001) found that the ratio of the WJA to the total umbilical cord 
area decreased significantly with advancing gestation. This is in agreement with Sloper et al. 
(1979) who reported that the water content of the umbilical cord is significantly lower in term 
than in preterm neonates with a progressive reduction from 30 weeks’ gestation to term. 
Similarly, Bruch et al. (1997) reported that the proportion of WJ was higher in UCs of fetuses 
delivered before 32 weeks of gestation than in those delivered between 37 and 41 weeks. In 
our study, the microscopic aspect of WJ was similar to that descripted by Kumar et al. (2013) 
in 6 Thoroughbred foals. However, on the contrary, we found just few elastic fibres scattered 
in UC section. As in humans (Takechi et al., 1993), the immunohistochemical analysis in 
normal umbilical cords revealed the presence of fibroblast cells positive for antibodies anti-
type II, IV and V collagen, anti-fibrillin, surrounded by a dense network of reticular fibres. 
Given their abundance, we could not confirm the presence of nervous fibres. Different from 
humans, in the equine UC, elastic fibres are less concentrated with an uneven pattern around 
the vessels. In this study, we highlighted similarities and differences between equine and 
human microscopic characteristics of the umbilical cord. Given the presence in human species 
of a strong correlation between these and specific pathological conditions of newborn and 
mother, further studies are needed, both on normal and high risk pregnancies to verify the 
presence of these correlations also in the equine species. 
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Introduction 
Both in human and equine species, mesenchymal stem cells (MSCs) from perinatal tissue, 
primarily amniotic membrane (AM) and Wharton’s jelly (WJ) may be particularly useful in 
the clinic for autologous transplantation for newborns and after banking in later stages of life. 
Even though they were originally clinically utilized for their differentiation and proliferation 
potential, MSCs are increasingly thought to improve tissue regeneration trough paracrine 
actions, involving extracellular microvesicles or secreted factors (Liang et al., 2014). Despite 
a lot of data have been reported on these features of human MSCs, only two reports are 
present on the ultrastructural characteristics and immunophenotype of adult and amniotic 
derived MSCs in equine species (Pascucci et al., 2014; Lange-Consiglio et al., 2016) . Given 
the increasing interest in using MSCs for regenerative medicine in horses, in the present 
study, for the first time in equine species, MSCs derived from AM and WJ were compared. 
Because MSCs may modulate the immune response, angiogenesis, apoptosis, oxidation level, 
migration, and themselves differentiation (Liang et al., 2014), migration, expression of 
stemness markers, immunophenotype, and ultrastructural features were analyzed. 
Furthermore, spheroids formation and differentiation potential were determined. 
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Materials and Methods 
Unless otherwise indicated, chemicals were purchased from Sigma-Aldrich, and laboratory 
plastics from Sarstedt Inc. 
Animals 
Samples were recovered from 13 Standardbred mares, housed at the Department of Veterinary 
Medical Sciences, University of Bologna, for attended delivery. Experimental procedures 
were approved by the Ethics Committee, University of Bologna. The written consent was 
given by the owners to allow tissues recovery for research purposes. 
Cell isolation and Doubling method 
Samples, recovered immediately after delivery, were washed under flowing water for 
removing straw or feces debris and stored in D-PBS (Dulbecco’s Phosphatase Buffered 
Solution) added with antibiotics (100 iu/ml penicillin and 100 µg/ml streptomycin), at 4°C, 
until processing. In the lab, cells were isolated as previously described (Iacono et al., 2012). 
Primary cells were plated in a 25 cm2 flask in Dulbecco’s Modified Essential Medium (D-
MEM) F12 Glutamax® (Gibco) supplemented with 10% FBS (Gibco) and antibiotics and 
incubated in a 5% CO2 humidified atmosphere at 38.5°C. At ~80-90% of confluence, cells 
were dissociated by 0.25% trypsin, counted and plated at the concentration of 5x103 
cells/cm2 as “Passage 1” (P1), and so on for the following passages. Calculation of cell-
doubling time (DT) and cell-doubling numbers (CD) was carried out according to the 
formulae of Rainaldi et al. (1991). 
Adhesion and Migration Assays 
In order to define differences between WJ and AM-MSCs, spheroid formation and migration 
test were performed. For adhesion assay, cells were cultured in ‘hanging drops’ (5.000 
cells/drop) for 24 h. Images were acquired by a Nikon Eclipse TE 2000-U microscope. 
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Spheroid areas were determined using ImageJ software Version 1.6 (imagej.nih.gov/ij/). 
Starting from the binary masks obtained by ImageJ, the volume of each spheroid was 
computed using ReViSP (sourceforge.net/projects/revisp/; Bellotti et al., 2016), a software 
specifically designed to accurately estimate the volume of spheroids and to render an image of 
their 3D surface. 
To assess cell migration potential, a scratch assay was carried out, as previously described 
(Liang et al., 2007). The distances of each scratch closure were calculated by ImageJ, and the 
migration percentages were calculated as previously reported (Rossi et al., 2014). 
In vitro differentiation 
At P3, in vitro differentiation potential of cells towards osteogenic, adipogenic and 
chondrogenic lineages was studied. Cells (5x103 cells ⁄cm2) were cultured under specific 
induction media (Table 3.1). As negative control, an equal number of cells was cultured in 
expansion medium. To cytologically evaluate differentiation, cells were fixed with 10% 
formalin at room temperature (RT) and stained with Oil Red O, Alcian Blue and Von Kossa 
for adipogenic, chondrogenic and osteogenic induction, respectively. Quantitative analysis of 
in vitro differentiation was performed by Image J. 
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Adipogenic medium 
(7 days) 
(Iacono et al., 2012) 
Chondrogenic Medium 
(21 days) 
(Iacono et al., 2012)
 
Osteogenic Medium 
(21 days) 
(Mizuno and Hyakusoku, 2003)
 
- DMEM F12 
- 15% Rabbit Serum 
- 0.5 mM IBMX
a
 
(removed after 3 days) 
- 1 μM DXMb 
(removed after 6 days) 
- 10 µg/mL insulin 
- 0.2 mM indomethacin 
- DMEM/TCM199 
- 1% FBS 
- 6.25 µg/mL insulin 
- 50 nM AA2P
c
 
- 0.1 μM DXMb 
-10 ng/mL hTGFβ1d 
 
- DMEM/TCM199 
- 10% FBS 
- 50 µM AA2P
c
 
- 0.1 μM DXMb 
- 10 mM BGPe 
 
 
Table 3.1. Specific induction media compositions.aIBMX: isobutylmethylxanthine, bDXM: 
Dexamethasone, cAA2P: Ascorbic Acid 2-Phosphate, hTGF: d human Transforming Growth Factor, 
e
BGP: Beta-Glycerophosphate. 
Immunocytochemistry (ICC) 
Cells at P3, cultured on ICC slides, were fixed with 4 % paraphormaldehyde (20 min at RT), 
then washed in phosphate buffer (PB). Cells were blocked in goat serum (10 %) for 1 h and 
incubated overnight with primary antibodies (Table 3.2), then they were washed in PB2 (PB + 
0.2 % BSA + 0.05 % saponin) and incubated with anti-mouse- or anti-rabbit- FITC 
conjugated secondary antibodies for 1 h. Nuclei were then labelled with Hoechst 33342. The 
excess of secondary antibody and Hoechst were removed by 3 washes with PB2. Images were 
obtained with a Nikon Eclipse E400 microscope, using the software Nikon NIS-Elements. 
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Primary Antibody Dilution 
α-SMA (α-smooth muscle actin) 
(Gene tex) 
1:500 
E-Cadherin  
(Cell Signaling Tech. #3195) 
1:200 
N-Cadherin 
(Biorbyt orb11100) 
1:100 
pan-Cytokeratin  
(Chemicon Inter.Millipore CBL234) 
1:250 
Table 3.2. Primary antibodies for ICC. 
 
Molecular Characterization 
One million cells were snap-frozen and RNA was extracted using Nucleo Spin® RNA kit 
(Macherey-Nagel) following the manufacturer’s instructions. cDNAs were synthesized by 
RevertAid RT Kit (ThermoFisher Scientific) and used directly in PCR reactions, following 
the instructions of Maxima Hot Start PCR Master Mix (2X) (ThermoFisher Scientific). The 
primers used are listed in Table 3.3. PCR products were visualized with ethidium bromide on 
a 2% agarose gel.  
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Primers References Sequences (5′→3′) bp 
MSC marker 
   
CD90 Mohanty et al., 2014 FW: TGCGAACTCCGCCTCTCT 
93 
  
RW: GCTTATGCCCTCGCACTTG 
CD73 Mohanty et al., 2014 
FW: GGGATTGTTGGATACACTTCAAAAG 
RW: GCTGCAACGCAGTGATTTCA 
90 
Ematopoietic 
markers    
CD34 Mohanty et al., 2014 FW: CACTAAACCCTCTACATCATTTTCTCCTA 
101 
  RW: GGCAGATACCTTGAGTCAATTTCA 
CD45 Mohanty et al., 2014 FW: TGATTCCCAGAAATGACCATGTA 
101 
  
RW: ACATTTTGGGCTTGTCCTGTAAC 
MHC markers 
   
MHC-I Corradetti et al., 2011 FW: GGAGAGGAGCAGAGATACA 
218 
  RW: CTGTCACTGTTTGCAGTCT 
MHC-II Corradetti et al., 2011 FW: TCTACACCTGCCAAGTG 
178 
  
RW: CCACCATGCCCTTTCTG 
ILs 
   
TNF α Jischa et al., 2008 FW: GCTCCAGACGGTGCTTGTG 
95 
  RW: GCCGATCACCCCAAAGTG 
IL-8 Jischa et al., 2008 FW: CGGTGCCAGTGCATCAAG 
81 
  RW: TGGCCCACTCTCAATCACTCT 
INF-γ Castagnetti et al., 2012 FW: GTGTGCGATTTTGGGTTCTTCTA 
235 
  RW: TTGAATGACCTGGTTATCT 
IL4 Castagnetti et al., 2012 FW: CAACTTCATCCAGGGATGCAA 
107 
  RW: CAGTCAGCTCCATGCACGAAT 
IL-β1 Castagnetti et al., 2012 FW: GAGGCAGCCATGGCAGCAGTA 
257 
  RW: TGTGAGCAGGGAACGGGTATCTT 
IL-6 Visser and Pollitt, 2011 FW: AAACCACCTCAAATGGACCACTA 
91 
  
RW: TTTTTCAGGGCAGAGATTTTGC 
Pluripotency 
markers    
OCT4 Desmarais et al., 2011 FW: TCCCAGGACATCAAAGCTCTGCAGA 
679 
  RW: TCAGTTTGAATGCATGGGAGAAGCCCAGA 
NANOG Desmarais et al., 2011 FW: GACAGCCCCGATTCATCCACCAG 
492 
  RW: GCACCAGGTCTGACTGTTCCAGG 
SOX2 Desmarais et al., 2011 FW: GGCGGCAACCAGAAGAACAG 
663 
  
RW: AGAAGAGGTAACCACGGGGG 
Housekeeping 
   
GAPDH Desmarais et al., 2011 FW: GTCCATGCCATCACTGCCAC 
262 
  RW: CCTGCTTCACCACCTTCTTG 
Table 3.3. Sequence of primers used for PCR analysis. 
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Transmission Electron Microscopy (TEM) 
Ultrastructural examination was performed on AM and WJ-MSCs at P3. After detaching 
cells, obtained pellet was fixed with 2.5% glutaraldehyde in 0.1 M PB, pH 7.3, for 1 h, at RT. 
Cells were then washed twice in PB and post-fixed with buffered 2% osmium tetroxide for 1 
h, at RT. They were finally dehydrated in a graded ethanol-propylen oxide series, pre-
infiltrated and embedded in Epon 812. Ultrathin sections (90 nm) were mounted on 200-mesh 
copper grids, stained with uranyl acetate and lead citrate, and examined by a Philips EM 208 
microscope (Center for Electron Microscopy, CUME, University of Perugia). 
Statistical Analysis 
Harvested WJ and AM (grams), CDs, DTs and percentages of migration are expressed as 
mean ± standard deviation (SD). Statistical analyses were performed using IBM SPSS 
Statistics 21 (IBM Corporation). Data were analysed, for normal distribution, using a Shapiro-
Wilk test, then using one-way ANOVA or a Student’s t-test (CDs and DTs). The 3D spheroid 
volumes and mean gray intensity of differentiated cells were compared using Mann-
Whithney’s U-test, due to their non-normal distribution. Significance was assessed for 
P<0.05. 
Results 
Cellular Growth 
As soon as after foals’ birth and immediately after foal detachment, UC (length ~15 cm) and 
AM samples were recovered. The mean weight of recovered jelly and AM were 5.22±3.34 g 
and 15.60±5.23 g, respectively. Adherent mononuclear cells, characterized by an 
homogeneous elongated fibroblast-like morphology were isolated from 13/13 (100%) WJ 
samples (Figure 3.1 A) and from 9/13 AM samples (69.2%) (Figure 3.1 B). Undifferentiated 
cells of both lines were passaged up to seven times; no changes in cell morphology was 
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observed throughout the culture period. DTs assay showed that AM and WJ-MSCs were able 
to divide for an extensive period in vitro. During P0 to P7, AM-MSCs showed a mean DT of 
1.49±0.34 days/CD, significantly lower than that recorded for WJ-MSCs (1.71±0.65 days/CD; 
P<0.05). No statistically significant differences were found in DTs among earlier culture 
passages in both cell lines (P>0.05). However, AM-MSCs start to grow old by P6, while WJ-
MSCs, despite an higher DT, get older later, starting from P7. In fact, at these passages, cells 
grew more slowly, as shown by significantly higher DTs compared to the earliest steps 
(P<0.05). By P7, total WJ and AM-MSCs cell doublings were similar (36.57±0.76 vs 
37.05±0.59; P>0.05; Figure 3.2). 
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Figure 3.1. A-B: Monolayer of rapidly expanding adherent spindle-shaped fibroblastoid cells, 
isolated from WJ (A) and AM (B), compatible with undifferentiated mesenchymal stem cell. C-H: In 
vitro differentiation studies. C-D: Chondrogenic induction in WJ (C) and AM-MSCs (D) over three 
weeks: Alcian Blue staining of glycosaminoglycans in cartilage matrix. E-F: Osteogenic induction in 
WJ (E) and AM-MSCs (F) over three weeks: von Kossa staining of extensive extracellular calcium 
deposition. G-H: Adipogenic induction in WJ (G) and AM-MSCs (H) over one week: Oil red O 
staining of extensive intracellular lipid droplet accumulation. 
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Figure 3.2. Number of cultured primary and passaged mesenchymal stem cells. All values reflect the 
mean ± standard deviation. 
 
Adhesion and Migration Assays 
Both AM and WJ cells formed spheroids when cultured in hanging drops (Figure 3.3 A; 
Figure 3.3 B). Average areas and volume of the spheroids formed by WJ-MSCs were 
significantly smaller than from AM-MSCs (P<0.05; Figure 3.3). Average percentage of 
migration, observed by scratch test, was statistically similar between cell lines (AM-MSCs vs 
WJ-MSCs: 34.14±4.51% vs 38.20±2.88%; P>0.05). 
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Figure 3.3. A-B: Spheroid culture: Attachment of the spheroid 24 h after seeding of WJ-MSCs (A) and 
AM-MSCs (B). C: 3D Volume reconstruction: Starting from the 2D images acquired by imaging in 
bright field each spheroid, volume, and 3D mesh were obtained by ReViSP. 
 
In vitro Differentiation 
Both cell lines were able to differentiate toward osteogenic, chondrogenic and adipogenic 
direction (Figure 3.1 C-H). However, WJ-MSCs showed a greater chondrogenic and 
osteogenic potential than AM-MSCs (P<0.05), characterized by a greater accumulation of 
extra-cellular mucosubstances and calcium deposits, as showed by Alcian Blu (Figure 3.1 C-
D) and Von Kossa stains respectively (Figure 3.1 E-F). 
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Phenotypic and Molecular Analysis by Immunocytochemistry and PCR 
Data observed by immunocytochemical staining of AM and WJ-MSCs are showed in Table 
6.4. Both cell lines clearly expressed mesenchymal marker, N-Cadherin (Figure 6.4 A-B) and 
the mesodermal marker alpha-SMA (Figure 3.4 C-D). On the contrary, WJ and AM- MSCs 
did not express pan-cytokeratin and E-Cadherin (Figure 3.4 E-F). 
Data recorded by PCR were reported in Table 3.5 and Figure 3.5. 
Antibody WJ-MSCs AM-MSCs 
α-SMA + + 
E-Cadherin - - 
N-Cadherin + + 
pan-Cytokeratin - - 
Table 3.4. Results obtained by ICC running on AM-MSCs and WJ-MSCs. 
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.  
Figure 3.4. Photomicrographs of immunostaining of WJ and AM-MSCs. A-B: Expression of the 
mesenchymal marker N-Cadherin in the WJ (A) and AM-MSCs (B). C-D: Expression of the 
mesenchymal marker alpha-SMA in the WJ (C) and AM-MSCs (D). E-F: Absence of expression of the 
epithelial marker Cytokeratin in WJ-MSCs (E) and absence of expression of E-Cadherin in AM-MSCs 
(F). All images, represent the merge of Hoechst and antibody staining. 
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Primers WJ-MSCs AM-MSCs 
MSC marker   
CD90 + + 
CD73 + + 
Ematopoietic markers   
CD34 + + 
CD45 - - 
MHC markers   
MHC-I + + 
MHC-II - - 
ILs   
TNF α - - 
IL-8 + + 
INF-γ - - 
IL4 - - 
IL-β1 + + 
IL-6 + + 
Pluripotency markers   
OCT4 + + 
NANOG - - 
SOX2 - - 
Table 3.5. Results obtained by PCR running on AM-MSCs and WJ-MSCs. 
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Figure 3.5. Reverse transcription-polymerase chain reaction analysis of immunomodulatory (TNF-α, 
IL-1β, IL-8, IL-6, IL-4, INF-γ) specific gene expression on WJ-MSCs (A) and AMMSCs (B) at P3. 
GAPDH was used as the reference gene. 
TEM 
TEM images are reported as Figure 3.6, 3.7, 3.8, 3.9 and 3.10. At low magnification, cells of 
both samples were quite small and uniform in size (diameter ranging from 10 to 15µm; 
Figure 3.6 A; Figure 3.8 B). AM-MSCs appeared generally well dissociated, while WJ-MSCs 
were frequently tightly adherent each other to form wide aggregates (Figure 3.8 A). Golgi 
complex was particularly well developed; it occupied a juxta-nuclear position and exhibited 
flattened cisternae, transport vesicles, and heterogeneous sized secreting granules. Some of 
them were very large and enclosed fine granular material (Figure 3.6 C-D; Figure 3.8 C). In 
both samples, the most relevant ultrastructural feature was represented by the very impressive 
number of large vacuolar bodies, up to 2 µm in diameter, scattered throughout the cytoplasm. 
They showed a variety of appearances and ranged from multivesicular bodies (MVB) 
comprising intralumenal nanovesicles of different sizes (30-500 nm), to endolysosomes and 
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autophagic bodies. These vacuoles were present in both cell types, but were particularly 
abundant in WJ-MSCs (Figure 3.7 A-C; Figure 3.8 A-B; Figure 3.9 A-C). The occurrence of 
membrane vesicles shedding from cell surface was observed in both samples. They ranged in 
size from about 100 nm to 500 nm and included electron-lucent, as well as moderately 
electron-dense vesicles isolated or aggregated nearby the cells (Figure 3.7 D; Figure 3.9 D). 
Complex macro-vesicles measuring 500 nm to 1μm and containing packed nanovesicles, 
frequently budded from the cell surface or were detected in the intercellular space (Figure 3.7 
E; Figure 3.9 E). Tunneling nanotubes were occasionally observed in both samples 
suggesting that this may be an additional mechanism of crosstalk between MSCs (Figure 3.7 
F; Figure 3.9 F). The most noteworthy difference between AM-MSCs and WJ-MSCs was the 
presence of an abundant extracellular fibrillar matrix (EFM) located in the intercellular spaces 
among WJ-MSCs (Figure 3.10 A-B). It was composed of a finely granular and moderately 
electron-dense ground substance populated by a loosely arranged network of reticular fibrils. 
These were uniformly thin and tend to run parallel to the cell surface. Abundant vesicles were 
entrapped among the fibrils (Figure 3.10 C). The intercellular spaces were devoid of collagen 
fibrils. EFM was present in very poor quantities in AM-MSCs (Figure 3.7 D). 
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Figure 3.6. AM-MSCs ultrastructural features. A: The micrograph depicts a single AM-MSC showing 
a roundish shape and a unique euchromatic irregularly-profiled nucleus. Scale bar, 5µm. B: A 
particular of the nucleus containing two prominent nucleoli. Scale bar, 2µm. C-D: Well developed 
Golgi complex and a group of large secreting granules. Scale bar, 500 nm and 1 µm. E: RER showing 
linear flat profiles and dilated cisternae. Scale bar, 1µm. F: A small group of typical mitochondria. 
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Figure 3.7. AM-MSCs ultrastructural features. A: Cell cytoplasm containing an enormous number of 
vacuolar elements, up to 2 µm in diameter. B-C: Maturing MVB containing endo-luminal vesicles. 
Scale bar, 500 nm. D: Membrane vesicles of heterogeneous sizes located in the peri-cellular space. 
Scale bar, 1 µm. E: A large vesicle (macro-vesicle) containing round-shaped smaller vesicles is 
placed in the intercellular space. Scale bar, 500 nm. F: A tunneling nanotube connecting two 
adjacent cells. Scale bar, 200 nm. 
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Figure 3.8. WJ-MSCs ultrastructural features. A: Low magnification image showing a group of 
reciprocally adherent WJ-MSCs with a single large euchromatic nucleus and a cytoplasm rich in 
vacuolar bodies. Scale bar, 5 µm. B: Electron micrograph of two WJ-MSCs showing a roundish shape 
and a unique euchromatic nucleus. The cell on the left is particularly rich of vacuolar bodies that are 
tightly packed inside its cytoplasm. Scale bar, 5 µm. C: Golgi apparatus in the juxta-nuclear area 
producing large secreting granules. Scale bar, 500 nm. D: Dilated cisternae of the RER. Scale bar, 1 
µm. 
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Figure 3.9. WJ-MSCs ultrastructural features. A: A particular of the cytoplasm containing a huge 
number of vacuolar structures, up to 2 µm in diameter. B: Vacuolar bodies characterized by endo-
luminal vesicles, very heterogeneous in size and morphology. Scale bar, 500 nm. C: A maturing MVB. 
Scale bar, 200 nm. D: Isolated (arrows) and aggregated (arrow head) extracellular vesicles located 
nearby the cell membrane. Scale bar, 500 nm. E: A large complex macro-vesicle budding from the cell 
surface. Scale bar, 500 nm. F: The image depicts a tunneling nanotube emerging from a cell. Scale 
bar, 100 nm. 
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Figure 3.10. Extracellular fibrillar matrix (EFM) in WJ-MSCs. A: EFM fills the space between two 
cells. Scale bar, 2 µm. B: Note the finely granular appearance of the ground substance and the fibril 
network. Scale bar, 500 nm. C: Extracellular vesicles entrapped among the fibrils of EFM. Scale bar, 
200 nm. 
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Discussion 
In this study, for the first time in equine species, we compared proliferation, migration, 
spheroids formation, trilineage differentiation capacity, expression of stemness markers, 
immunophenotype and ultrastructural features of MSCs derived from WJ and AM. From both 
tissues, cells with mesenchymal morphology were isolated. However, in the present study, 
MSCs were isolated from all samples by collagenase digestion technique only for WJ. No 
other reports exist on the successful isolation rate from equine WJ and AM. 
Despite the lower isolation rate, AM-MSCs showed a higher proliferation rate compared to 
WJ-MSCs. However, in both cell types, as in humans (Pasquinelli et al., 2007), TEM 
examination revealed an highly metabolic and synthetic nature, demonstrated by euchromatic 
nucleus, prominent nucleoli, abundant nuclear pores as well as by well developed RER and 
Golgi complex. Furthermore, the higher DTs did not correlate with total cell doubling 
number, because AM-MSCs began to grow old earlier, as registered by a higher DT at P6 of 
in vitro culture. These findings support previous observations by Vidal et al. (2012), which 
observed population doubling and senescence of different lines of equine MSCs, including 
umbilical cord matrix MSCs. 
Beyond the growth curve, migration ability is an important feature of MSCs because of its 
fundamental significance for systemic application (Li et al., 2009; Burk et al., 2013). No 
differences were found between WJ-MSCs and AM-MSCs in migration ability. 
Since the adhesion capability is related and enhanced to differentiation potential (Wang et al., 
2009; Kavanagh et al., 2014; Sart et al., 2014), in the present study spheroid formation in 
vitro was assessed using the hanging drop method. Cell derived from WJ showed a higher 
adhesion ability, forming smaller spheroids, as determined by ReVisp. As recently observed 
for human WJ and AM-MSCs (Subramanian et al., 2015), also in horses the ability to form 
spheroids in vitro is related to an higher differentiation potential. In fact, in this study, the 
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analysis of differentiated cells by Image J, showed a higher WJ-MSCs chondrogenic and 
osteogenic potential. 
The foetal adnexa derived MSCs demonstrate the characteristics defined by the International 
Society for Cellular Therapy criteria (Dominici et al., 2006), except for the CD34; these 
results confirmed that the lack of CD34 marker cannot be considered an essential requirement 
of a stem cell. Indeed its expression seems to depend on environment and in vitro culture 
passages (Lin et al., 2012). Furthermore, in the present study, anti-inflammatory and pro-
inflammatory factors produced by foetal adnexa MSCs were investigated for the first time in 
the horse. As expected, at RT-PCR, these cells resulted negative for TNF-α, IL-4 and INF, 
cytokines produced only after in vitro stimulation (De Schauwer et al., 2014). On the 
contrary, both cell lines expressed, on their cDNA, IL-1β, IL-6 and IL-8; this cytokines are 
important mediators of the inflammatory response, involved in a variety of cellular activities, 
including cell proliferation, differentiation, apoptosis, chemotaxis, angiogenesis and 
hematopoiesis (Lamalice et al., 2007). Data registered in this study confirmed those already 
reported in human WJ-MSCs (Fong et al., 2012; Choi et al., 2013) and AM-MSCs 
(Yazdanpanah et al., 2015). These factors are involved in the complex interaction between 
MSCs and the tissue microenvironment as well as production of membrane vesicles, 
containing molecules such as short peptides, proteins, lipids, and various forms of RNAs 
(György et al., 2011). 
As previously observed in adult equine cells (Pascucci et al., 2014), the great number of 
vacuolar bodies that, actually, were not empty but contained small, medium and large 
intralumenal vesicles maturing from their internal membrane, may be interpreted as the ability 
of both cell types to produce a huge variety of “secreting” molecules. These are likely 
enclosed inside vesicles of different types with the aim to segregate and organize, in space 
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and time, the release of cell products in the extracellular milieu. Maybe we hypothesized, in 
addition, that the described structures represent a mechanism efficiently recycling cell 
constituents. The intense proliferating and metabolic activity, in fact, makes it necessary 
constantly renewing sub-cellular components, especially membrane fractions. The main 
difference between AM-MSCs and WJ-MSCs attained the presence of an abundant 
extracellular fibrillar matrix in the intercellular spaces among WJ-MSCs; it probably 
determines a tight intercellular adhesion even after trypsin treatment and is responsible of the 
observation of cell aggregates at TEM analysis. It is well known that these cells, in vivo, are 
immersed in a mucoid connective matrix. It seems evident that WJ-MSC isolation and 
cultivation in vitro does not affect their ability to produce extracellular matrix. 
It has emerged from the present study that cells isolated from different foetal origin matrices 
exhibit different morphological, molecular and differentiation potential. Equine WJ could be 
considered as a viable source for MSCs with reliable migration and differentiation capacities, 
and it is therefore a convenient cell source for autologous or allogeneic regenerative therapies. 
Although the molecular content and functional activities of MVs produced by WJ and AM-
MSCs remain to be characterized, the results of the present study indicated that MSCs from 
equine foetal adnexa could be able to influence endogenous cells trough paracrine action and 
constitutively produce MVs that may be partly responsible for their paracrine activity. 
However, further investigation is needed to find the best protocols for isolation and in vitro 
differentiation for AM-MSCs. Moreover, further in vivo studies will be required to 
substantiate our in vitro findings. 
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Introduction 
Mesenchymal stem cells (MSCs) are defined as a population of multipotent stem cells capable 
of plastic-adherence when maintained in standard culture conditions, expression of typical 
mesenchymal surface molecules (CD105, CD73 and CD90) and lacking hematopoietic ones 
(CD45, CD34, CD14 or CD11b, CD79α or CD19 and HLA-DR), and able to differentiate into 
osteoblasts, adipocytes and chondroblasts in vitro (Dominici et al., 2006). Since these 
properties, MSCs offer a great chance for cell-based therapies and tissue engineering 
applications. 
Placental tissues and foetal fluids represent a source of cells for regenerative medicine. They 
are readily available and easily procured without invasive procedures. MSCs from foetal 
fluids and adnexa are defined as an intermediate between embryonic and adult stem cells, due 
to the preservation of some characteristics typical of the primitive native layers. 
Umbilical cord is routinely discarded at parturition and its extracorporeal nature facilitates 
isolation by eliminating the invasive and discomfort extraction procedures as well as patient 
risks that attend adult stem cells isolation. Most significantly, the comparatively large volume 
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of umbilical cord and ease of physical manipulation theoretically increase the number of stem 
cells that can be extracted, which makes it possible to get substantial number of cells in 
several passages without need of long term culture and extensive expansion ex vivo. Both in 
human and animals, multipotent stem cells are isolated from the mesenchyme-like cushioning 
material called Wharton's jelly (WJ) found between the vessels of the umbilical cord 
(Vangsness et al., 2015; Iacono et al., 2015). WJ cells represent a unique, easily accessible, 
and non-controversial source of early stem cells that can be readily manipulated. MSCs 
derived from Wharton's jelly (WJ-MSCs) are easier to isolate and expand than MSCs from 
other foetal and adult tissues, and impact fields such as regenerative medicine, biotechnology 
and agriculture (Troyer and Weiss, 2008). 
The development of large animal experimental models, including horse, may open alternative 
strategies for investigating placental MSCs physiology and potential application for human 
and veterinary regenerative medicine. The objective of this study was to compare human and 
equine WJ-MSCSs obtained following the same protocols in order to define similarities and 
differences, at ultrastructural level also, that can be useful in understanding specie-specific 
characteristics and in defining new animal models. 
 
Materials and Methods 
Chemicals were obtained from Sigma Aldrich (St. Louis, MO, USA) and laboratory 
plasticware was from Sarstedt Inc. (Newton, NC, USA) and Corning (Corning, NY, USA), 
unless otherwise stated. 
Human and equine cells isolation and expansion 
hWJ-MSCs and eWJ-MSCs were obtained from tissue of umbilical cords of respectively 7 
and 10 full-term pregnancies. Informed consent was obtained from each patient according to 
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the guidelines of the National Bioethics Committee and the samples were treated following a 
protocol approved by the University of Bologna. 
Wharton’s jelly was cut in small fragments and digested with collagenase (Gibco, Thermo 
Fisher, Monza, Italy) 0.1% (w/v) in phosphate buffer saline (PBS) at 37°C approximately for 
3 hours. Then, samples were washed in PBS with 10% (v/v) foetal bovine serum (FBS) 
(Gibco, Thermo Fisher, Monza, Italy) several times, centrifuged at 400 g for 50 minutes and 
finally re-suspended in DMEM/F12 Glutamax
®
 medium (Gibco, Thermo Fisher, Monza, 
Italy) supplemented with 10% FBS (v/v), 1% (v/v) penicillin and streptomycin (Gibco, 
Thermo Fisher, Monza, Italy). Primary cells were plated in a 25 cm
2
 flask, as “Passage 0” 
(P0), at a density of 5x10
3
 cell/cm
2
 and incubated in 5% (v/v) CO2 humidified atmosphere at 
37°C (human) or 38.5°C (equine). The medium was completely replaced every 3 days until 
the adherent cell population reached about 80% confluence. At this point, the adherent 
primary MSCs were passaged by digestion with 0.25% trypsin-EDTA, counted with a 
haemocytometer, and reseeded as P1 at 5x10
3 
cells/cm
2
. For the subsequent passages (P1-P6), 
cells were inoculated in 25 cm
2
 flasks at 5x10
3
 cells/cm
2
 and allowed to multiply to 90% 
confluence before trypsinization and successive passage. Cell-doubling time (DT) and cell-
doubling numbers (CD) and cell culture time (CT) were calculated from haemocytometer 
counts for each passage according to the following two formulae (Rainaldi et al., 1991): 
CD= ln(Nf/Ni)/ln(2) 
DT= CT/CD 
where Nf and Ni are the final and initial number of cells, respectively. 
Cells at P3 were used for the subsequent determination and characterization. 
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Scratch assay 
Cells (4.8 x 10
4
) were seeded on 35 mm petri dishes and cultured until confluence in the same 
conditions as previously described. Scratches were made using 1 mL pipette tips, washed with 
medium and allowed to grow for additional 24 h. Immediately after the scratch and at the end 
of the culture, cells were observed under an inverted light microscope (Motic AE21, VWR 
International Srl, Milan, Italy; Eclipse TE 2000u, Nikon Instruments Spa, Florence, Italy) and 
photographed by CCD camera (Visicam 3.0, VWR International Srl, Milan, Italy; DS-Fi2, 
Nikon Instruments Spa, Florence, Italy). Gap distance of the wound was measured using 
Image J software (Version 1.48s; National Institutes of Health, USA). The migration 
percentages were calculated using the following formula: 
[(distance at time 0 – distance at 24 h) * 100] / distance at time 0 
Adhesion test (hanging drop culture) 
25 µl drops of cell medium, containing approximately 5x10
3
 cells each, were pipetted on the 
inner side of the lid of a 90 mm petri dish, which was gently inverted and allowed to grow for 
48 h in the same cell culture conditions as previously described. Then, cells were observed 
under an inverted light microscope (Motic AE21, VWR International Srl, Milan, Italy; 
Eclipse TE 2000u, Nikon Instruments Spa, Florence, Italy) and photographed by CCD camera 
(Visicam 3.0, VWR International Srl, Milan, Italy; DS-Fi2, Nikon Instruments Spa, Florence, 
Italy). Area and volume of cell masses obtained were obtained by using Image J software and 
ReVisp software (Piccinini et al., 2015). 
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Immunophenotyping by flow cytometry 
The cells obtained were checked for their staminal profile by FACSCalibur flow cytometry 
system (Becton Dickinson, CA, USA). 2.5 × 10
5
 cells were removed with Dulbecco PBS and 
were then stained for 45 min with the following antibodies: fluorescein isothiocyanate-
(FITC)-labeled mouse anti-human CD90 (StemCell Technologies, Milan, Italy), CD105, 
CD14, CD19, (Diaclone, France), R-phycoerythrin-(PE)-labeled mouse anti human CD34, 
CD45 (Diaclone, France), CD73 (Becton Dickinson, CA, USA), and anti HLA-DR (Diaclone, 
France). The control for FITC- or PE-coupled antibodies was isotypic mouse IgG1. The data 
were evaluated using CellQuest software (Becton Dickinson, CA, USA). 
Transmission Electron Microscopy (TEM) 
WJ-MSCs were fixed with 2.5% (v/v) glutaraldehyde in 0.1 mol/l cacodylate buffer for 2 h 
and post fixed with a solution of 1% (w/v) osmium tetroxide in 0.1 mol/l cacodylate buffer. 
The cells were then embedded in epoxy resins after a graded-ethanol serial dehydration step. 
The embedded cells were sectioned into ultrathin slices, stained by uranyl acetate solution and 
lead citrate, and then observed with transmission electron microscope CM10 Philips (FEI 
Company, Eindhoven, The Netherlands) at an accelerating voltage of 80 kV. Images were 
recorded by Megaview III digital camera (FEI Company, Eindhoven, The Netherlands). 
Cellular details were calculated on 20 different fields at 19000 magnification by Megaview 
software system (FEI Company, Eindhoven, The Netherlands). 
Differentiation 
WJ-MSCs were seeded in six-well culture plates at a density of 1.25x10
4
 in the same culture 
condition as previously described. After 24 h, medium was completely replaced with 
adipogenic, chondrogenic and ostegenic induction medium consisting of DMEM/F12 medium 
supplemented as summarized in Table 4.1. To assess differentiation, cells were fixed with 
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10% (w/v) formalin for 1 h, and then stained. Oil Red O (0.3% (v/v) in 60% (v/v) 
isopropanol) was used to evaluate formation of neutral lipid vacuoles after 10 days of 
adipogenic differentiation. Chondrogenic and osteogenic differentiation were assessed after 
21 days of culture in induction media by using 1% (w/v) Alcian Blue in 3% (v/v) acetic acid 
solution and 2% (w/v) Alizarin Red S (pH 4.1–4.3) solution, respectively. Cells were 
observed under an inverted light microscope (Motic AE21, VWR International Srl, Milan, 
Italy; Eclipse TE 2000u, Nikon Instruments Spa, Florence, Italy) and photographed by CCD 
camera (Visicam 3.0, VWR International Srl, Milan, Italy; DS-Fi2, Nikon Instruments Spa, 
Florence, Italy). Control samples consisted in WJ-MSCs cultured for the same period of time 
in DMEM/F12 plus 2% (v/v) FBS. 
Images obtained after differentiation were analysed for colour intensity using Image J 
software (National Institutes of Health, USA) in order to compare the differentiation ability of 
human and equine WJ-MSCs. 
Medium Composition 
Adipogenic 
 
DMEM/F12 + 15% (v/v) rabbit serum + 1 µmol/l DXM (removed after 6 
days) +0.5 mmol/l IBMX (removed after 3 days), 10 µg/ml insulin, 0.2 
mmol/l indomethacin 
Chondrogenic 
 
DMEM/F12 + 1% (v/v) FBS + 6.25 µg/ml insulin + 50 nM AA2P, 0.1 µmol/l 
DXM, 10 ng/ml hTGFβ1 
Osteogenic DMEM/F12 + 10% (v/v) FBS + 10 mmol/l BGP + 0.1 µmol/l DXM + 50 
µmol/l AA2P 
Table 4.1. Media used for tri-lineage differentiation of human and equine WJ-MSCs. DXM: 
dexamethasone ; IBMX: 3-isobutyl-1-methylxanthine; FBS: foetal bovine serum; AA2P: 2-phospho-L-
ascorbic acid trisodium salt; hTGFβ1: human transforming growth factor; BGP. beta-
glycerophosphate. 
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Statistical analysis 
Growth curves were obtained from 3 samples per species. Tests and analysis were performed 
on P3 cells. Scratch and adhesion assays were done on 2 samples for each species, collecting 
data from 5 replicates per sample. FACS analysis, TEM and differentiation were performed 
on 3 sample for each species. Data are expressed as mean ± SD. Data were analysed for 
normality using a Shapiro-Wilk test. Statistical differences were assessed by Student t Test or 
Mann-Whitney U test and by Friedman test using the software IBM SPSS Statistics 23 (IBM 
Corporation, Milan, Italy). Significance was assessed for P<0.05. 
 
Results 
Primary culture of WJ-MSCs 
Both human and equine cells obtained from each umbilical cord were adherent cells showing 
a fibroblast like morphology (Figure 4.1 A,B). Cells were cultured up to P6 and mean DT 
was higher (P<0.05) for human (6.5 ± 4.3) than equine (3.5 ± 2.4) cells. No significant 
differences (P>0.05) between all passages were observed for human cells (Figure 4.2 A) 
while eWJ-MSCs showed a trend to DT increasing starting from P4 (P<0.05) (Figure 4.2 B). 
Total cell doublings after 44 days of culture were higher (P<0.05) in the horse (20.3 ± 1.7) as 
compared to hWJ-MSCs (8.7 ± 2.4). 
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Figure 4.1. (A) Population of hWJ-MSCs (Ematossilin staining, phase contrast) after 5 days of cell 
culture and (B) of eWJ-MSCs after 9 days of culture. The adherent cells showed a spindle-shape 
morphology (scale bars 30 um). 
 
 
Figure 4.2. Doubling times of hWJ-MSCs (A) and eWJ-MSCs (B) over six passages of culture. * 
P<0.05. 
 
Scratch assay 
In order to evaluate the ability of WJSCMs to migrate, a scratch assay was performed. Results 
showed, in both species, a good capacity of cells to proliferate and partially cover the cell free 
area after 24 h of culture (Figure 4.3 A-D), but hWJMSC reached a higher (P<0.05) migration 
rate (58.5± 4.7%) as compared to eWJ-MSCs (43.0± 7.7%). 
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Figure 4.3. Scratch assay on hWJ-MSCs at t0 (A) and after 24 h (B) of cell growth. The same on eWJ-
MSCs at t0 (C) and after 24h (D) (scale bar 90 um). 
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Adhesion assay 
In order to evaluate the ability of WJ-MSCs to adhere each other, the adhesion assay was 
carried out. Results showed a higher ability for eWJ-MSCs than hWJ-MSCs to aggregate each 
other, as demonstrated by the lower (P<0.05) mean volume of the equine spheroids compared 
to human ones (Figure 4.4 A). Furthermore, the lower adhesion ability of hWJMSC was also 
observed since more frequently (about 50%) generating micro-masses (Figure 4.4 B). 
 
Figure 4.4. Adhesion assay. (A) Volume reconstruction and visualization of an equine (on the left) and 
a human (on the right) WJ-MSCs spheroid obtained after 48 h of hanging drop culture, as assessed by 
ReVisp (scale in pixels). (B) Low ability of hWJ-MSCs to aggregate each other making micro- masses 
(scale bar 90um). 
 
Immunophenotyping of WJ-MSCs by flow cytometry 
In order to evaluate the mesenchymal phenotype, both human and equine WJ-MSCs obtained 
were characterize by flow cytometry. According to Domenici et al. (2006), the expression of 
the following markers was evaluated: CD105, CD73, CD90, CD14, CD19, CD34, CD45 and 
HLA-DR. hWJ-MSCs were highly positive for CD105, CD73 and CD90 and negative for 
CD34, CD19, CD45, CD14 and HLA-DR (Table 4.2 and Figure 4.5). Using a pre-set 
antibody panel for human cells, most of the clones used were not suitable for equine cells, 
since cross-reactivity was lacking, as previously demonstrated (De Schauwer et al., 2012; 
Ibrahim and Steinbach, 2012; Iacono et al., 2015). As consequence, eWJ-MSCs were 
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evaluated only for the expression of CD90 (Table 4.2 and Figure 4.5). Furthermore, no cross-
reactivity CD 19 (clone B-C3) was demonstrated, as it was not able to bind equine 
lymphocytes (positive control, data not shown). 
 
Group 
CD105 
(%) 
CD90 
(%) 
CD73 
(%) 
CD34 
(%) 
CD19 
(%) 
CD45 
(%) 
HLA-DR 
(%) 
hWJMSC 99.98 100.00 99.98 1.53 1.76 1.35 0.87 
eWJMSC n/a 92.57 n/a n/a n/a n/a n/a 
Table 4.2. Flow cytometry analysis of human and equine Wharton’s jelly derived mesenchymal stem 
cells. hWJMSC: human Wharton’s jelly derived mesenchymal stem cells; eWJMSC: equine Wharton’s 
jelly derived mesenchymal stem cells; n/a: not applicable (no antibody cross-reactivity). 
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Figure 4.5. Flow cytometry analysis of hWJ-MSCs for (A) CD105, (B) CD90, (C) CD73, (D) CD34, 
(E) CD19, (F) CD45, (G) HLA-DR and of eWJ-MSCs for (H) CD90 and (I) CD19. 
 
TEM analysis 
TEM analysis was performed to evaluate ultrastructure of cells with the final goal to establish 
morphological parameters useful for the classification and comparison of human and equine 
WJ-MSCs. 
hWJ-MSCs are spindle like shape (Figure 4.6 A) cells with an average area of 600 um
2
, 
characterized by large euchromatic nucleus and one nucleolus each (Figure 4.6 A). At middle 
magnification, a widely developed Golgi apparatus (Figure 4.6 B) surrounded by several 
secretory vesicles with a diameter ranging from 70 to 200 nm, rough endoplasmic reticulum 
(RER) with cisternae showing moderately electron dense material and mitochondria with 
evident internal cristae were observed (Figure 4.6 C). An high number of free ribosomes, 
randomly distributed, characterized the cytoplasm. Several autophagic vesicles and 
autophagolysosomes with an average diameter of 600 nm, were observed in the cytoplasm of 
hWJ-MSCs (Figure 4.6 D). A few intercellular junctions were observed (Figure 4.6 D insert). 
EWJ-MSCs appear as large fibroblastic like cells, with an average diameter of 700 um
2
, 
showing euchromatic nucleus and a variable number of nucleolus ranging from 2 to 6 each 
cell (Figure 4.6 E). At higher magnification, Golgi apparatus, often in more than one each 
cell, surrounded by several small vesicles with a diameter ranging from 50 to 250 nm, 
widespread in the cytoplasm (Figure 4.6 F). RER cisternae were numerous and partially 
enlarged, showing a moderately electron dense material. An high number of elongate 
mitochondria with evident internal cristae were also observed (Figure 4.6 G). Several 
autophagy vesicles and autophagolysosomes, with an average diameter of 700 nm 
characterized the cytoplasm (Figure 4.6 H). An high number of free ribosomes and a few 
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lipid droplets were randomly observed in the cytoplasm. Cell junctions were observed (Figure 
4.6 H insert). 
 
Figure 4.6. TEM analysis of hWJ-MSCs. (A) cluster of cells showing a spindle shape morphology 
(scale bar 20um); (B) detail of Golgi apparatus (black arrow) (scale bar 500nm) (C) detail of RER 
(black arrow) and mitochondria (m) (scale bar 1000nm); (D) detail of cytoplasm showing autophagy 
vesicles and autophagolysosomes (black arrowhead), RER (black arrow) and mitochondria (m) (scale 
bar: 1000nm). Detail of a cell junction (insert; scale bar: 500nm). TEM analysis of eWJ-MSCs. (E) 
cluster of cells showing a spindle shape morphology (scale bar 10um); (F) detail of Golgi (black 
arrows), mitochondria (m) and autophagy vesicle (black arrowhead) (scale bar 500 nm); (G) detail of 
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mitochondria (m) and free ribosomes (scale bar 1000 nm); (H) numerous autophagy vesicles and 
autophagolysosomes (black arrowhead) and some mitochondria (m) were detected in the cytoplasm 
(scale bar: 1000nm) Detail of a cell junction (insert; scale bar: 500nm). 
Differentiation 
Oil Red O showed the presence of several fat droplets in almost all cells after 10 days of 
differentiation both in human (Figure 4.7 A) and equine (Figure 4.8 A) cells, compared to 
control samples in which no fat droplets were detected (Figure 4.7 B, Figure 4.8 B). 
Also for chondrogenic differentiation, control samples stained negative for Alcian Blue 
(Figure 4.7 D; Figure 4.8 D). while a strong blue colour in cells and extracellular matrix after 
21 days of differentiation in both species (Figure 4.7 C human; Figure 4.8 C equine) 
suggested a gradual deposition of glycosaminoglycans. 
A strong red colour in cells and extracellular matrix after 21 days of osteogenic differentiation 
in human (Figure 4.7 E) and equine (Figure 4.8 E) cells confirmed the deposition of calcium, 
and the presence of mineralized extracellular matrix, which was undetectable by alizarin red 
in control samples (Figure 4.7 F; Figure 4.8 F). 
No differences (P>0.05) in the level of adipogenic differentiation were observed between 
human and equine WJ-MSCs, while eWJ-MSCs showed an higher (P<0.05) chondrogenic 
and osteogenic differentiation potential as compared to human counterparts, as demonstrated 
by the lower mean grey value observed after colour intensity analysis of differentiation 
images (Figure 4.9). 
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Figure 4.7. (A) adipogenic differentiation of hWJ-MSCs after 10 days of induction (Oil Red O 
staining , scale bar 20 um); (B) control samples consisting in hWJ-MSCs cultured with cell medium 
without any adipogenic factors (Oil Red O staining, scale bar 20 um); (C) chondrogenic 
differentiation of hWJUMSCs after 21 days of induction (Alcian Blue staining, scale bar 20 um); (D) 
control samples consisting in hWJ-MSCs cultured with cell medium without any chondrogenic factors 
(Alcian Blue staining, scale bar 20 um); (E) osteogenic differentiation of hWJ-MSCs after 21 days of 
induction (Alizarin Red staining, scale bar 20 um); (F) control samples consisting in hWJ-MSCs 
cultured with cell medium without any osteogenic factors (Alizarin Red staining, scale bar 20 um). 
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Figure 4.8. (A) adipogenic differentiation of eWJ-MSCs after 10 days of induction (Oil Red O staining 
, scale bar 50 um); (B) control samples consisting in eWJ-MSCs cultured with cell medium without 
any adipogenic factors (Oil Red O staining, scale bar 50 um); (C) chondrogenic differentiation of 
eWJ-MSCs after 21 days of induction (Alcian Blue staining, scale bar 50 um); (D) control samples 
consisting in eWJ-MSCs cultured with cell medium without any chondrogenic factors (Alcian Blue 
staining, scale bar 50 um); (E) osteogenic differentiation of eWJ-MSCs after 21 days of induction 
(Alizarin Red staining, scale bar 50 um); (F) control samples consisting in eWJ-MSCs cultured with 
cell medium without any osteogenic factors (Alizarin Red staining, scale bar 50 um). 
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 Figure 4.9. Mean grey values (inversely related to differentiation potential) obtained after colour 
intensity analysis of adipogenic, chondrogenic and osteogenic differentiation images of equine (white) 
and human (black) WJ-MSCs. * P<0.05. 
 
Discussion 
In this study, MSCs were successfully isolated from equine and human Wharton’s jelly by 
tissue digestion using the same protocol. Further analysis of proliferation, migration, 
adhesion, immunophenotyping, tri-lineage differentiation and TEM behaviour of isolated 
MSCs was performed for comparative evaluation of WJ-MSCs from both species. TEM 
analysis confirmed the presence of an intense metabolism and secretory activity, all 
morphological features linked with the maintenance of cell stemness and survival. 
Interestingly, major differences between cellular properties of hWJ-MSCs and eWJ-MSCs 
were observed in the proliferation, migration, adhesion abilities and also in differentiation 
potential. 
For this study, the horse was chosen as an appropriate animal model, since there are 
pathophysiological similarities between human and equine orthopaedic diseases (Patterson et 
al., 2012). Furthermore, in equine medicine the treatment of orthopaedic injuries with MSCs 
S E C T I O N  I I - S t u d i e s  o n  e q u i n e  M e s e n c h y m a l  S t e m  C e l l s | 97 
 
is currently widely used (Smith, 2008; Crovace et al., 2010; Godwin et al., 2012). Wharton’s 
jelly is a plentiful and inexpensive source of cells that fit into the category of primitive 
stromal cells (Troyer and Weiss, 2008), so in the present study it was chosen as donor tissue. 
In both species, TEM analysis showed cells with a fibroblast shape, large nucleus, well 
developed RER and Golgi apparatus surrounded by several mitochondria, ultrastructural 
characteristics connected with a proliferating status and an intense synthetic and metabolic 
activity, which characterize mesenchymal stem cells (Pasquinelli et al. 2007; Pascucci et al., 
2010). Equine WJ-MSCs showed a higher number of nucleolus, ranging from 2 to 6, 
comparing to the human WJ-MSCs, in which one nucleolus was always detected. The number 
of nucleolus is correlated with an intense protein synthesis and metabolic activity due to an 
increased demand for proteins during cell growth and proliferation which reflects an increase 
in protein synthetic capacity by upregulating ribosome biogenesis (Orsolic et al., 2016). The 
higher number of nucleolus in eWJ-MSCs is in agreement with our findings on cellular 
properties of eWJ-MSCs and hWJ-MSCs in which eWJ-MSCs demonstrated a higher 
proliferation, adhesion abilities and differentiation potential compared to hWJ-MSCs.  
Furthermore, in both species a large amount of vesicles was observed in the cytoplasm, as 
previously reported in equine adipose derived mesenchymal stem cells where an high amount 
of primary endocytic vesicles, early endosomes, late endosomes, endolysosomes and 
lysosomes (Pascucci et al., 2010). In human mesenchymal stem cells, it was also reported the 
presence of autophagic vacuoles inside amnion MSCs (Pasquinelli et al., 2007; Teti et al., 
2012), in agreement with our observations in which a high number of autophagy vesicles and 
autophagosomes were detected. Recently, it has been demonstrated the presence of a 
constitutive autophagy as a cytoprotective and cellular quality control mechanisms to balance 
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protein and organelle turnover, crucial for the maintenance of stemness (Garcia-Prat et al., 
2016; Sbrana et al., 2016). 
The first observation arose from proliferation assay is that equine WJ-MSCs grew more 
rapidly in comparison to human cells. Mean doubling time for equine cells was lower, but 
while human cells did not exhibit variation in the first 6 passages, an increase was observed 
by P4 for eWJ-MSCs. The quite early slowing down in growth of eWJ-MSCs observed in this 
study has never been observed before in our laboratory, and subsequently mean doubling time 
was higher than in previous studies (Iacono et al., 2012). A possible explanation could be that, 
for the present research, the culture medium was changed, and equine cells were cultured in 
the same medium routinely used for human MSCs (Mattioli-Belmonte et al., 2015). Further 
studies culturing eWJ-MSCs in different conditions are needed to ascertain such hypothesis. 
Migration potential of MSCs is considered important for their integration into the host tissue 
during therapeutic applications (Li et al., 2009). In the present study, hWJ-MSCs showed a 
trend towards increased migration activity in comparison to eWJ-MSCs, suggesting their graft 
integration in vivo may be enhanced. This finding was surprising, given that human cells 
showed a slower doubling time, but could be partially explained by the observed lower cell-
to-cell adhesion potential. 
In fact, hWJ-MSCs spheroids after hanging drop culture were larger than those formed by 
eWJ-MSCs, and quite often fragmented, demonstrating a lower self-assembly ability. Self-
assembly of MSCs into aggregates has significant implication in their applications in cell 
therapy and tissue regeneration (Sart et al., 2014). 3D spheroid culture system contributes to 
an optimization for efficient in vitro differentiation of MSCs (Wang et al., 2009) and in vivo 
MSC 3D transplantation of synovial MSC aggregates promoted cartilage tissue regeneration 
in a rabbit model (Suzuki et al., 2012). 
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In this study, no significant differences were observed in the adipogenic differentiation 
capacity between hWJ-MSCs and eWJ-MSCs, on the contrary, eWJ-MSCs produced more 
extracellular matrix both in chondrogenic and osteogenic differentiation, as confirmed by an 
higher intensity of staining. Differentiations were performed using standard protocols 
described in the literature for human MSCs (Mizuno and Hyakusoku, 2003), with some 
modifications (Iacono et al., 2012): for the chondrogenic differentiation 0.1 mM 
dexamethasone was added, while rabbit serum was used for the adipogenic differentiation 
protocol. Indeed, it has been reported that rabbit serum enhances adipogenic differentiation 
(Janderova et al., 2003). 
Analysis of surface marker expression patterns provided further insights into the 
characteristics of human MSCs, but only one antibody of the panel available was cross-
reacting with equine epitopes. This study confirms what already observed by others in the 
horse (De Schauwer et al., 2011; Ibrahim and Steinbach, 2012; Iacono et al., 2015), and adds 
to the list a new antibody that does not recognise the corresponding equine epitope (CD 19, 
clone B-C3). 
In conclusion, our findings indicate that MSCs isolated from umbilical of different species, 
have a similar ultrastructure compatible with mesenchymal stem phenotype, which makes 
them to have different biological proprieties. This study helps to better clarify the specie-
specific characteristics and in defining new animal models. 
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CHAPTER 5 
ULTRASTRUCTURAL COMPARISON BETWEEN EQUINE ADULT 
AND FOETAL MESENCHYMAL STEM CELLS 
Article in preparation 
Department of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, Bologna, Italy. Research in 
collaboration with Prof Janina Burk (Translational Centre of Regenerative Medicine of University of Leipzig, 
Germany) and with Prof. Mirella Falconi and Dr. Gabriella Teti (Department for Biomedical and Neuromotor 
Sciences, University of Bologna, Italy) 
Introduction 
Mesenchymal stem cells (MSCs), also known as multipotent stromal cells or mesenchymal 
progenitor cells (Dominici et al., 2006), are of increasing interest in the regenerative medicine 
field. Their application requires the ability to collect a large number of cells in a noninvasive 
way, the availability of highly proliferative cells that are able to differentiate, and the need to 
create cells for cryogenic banking (Lange Consiglio et al., 2013). For practical reasons, the 
most common harvest method employed clinically is bone marrow (BM) or adipose tissue 
(AT) harvest, although umbilical cord blood banks are rapidly expanding (Bourzac et al., 
2010). 
The aim of the study was to compare and describe property and characteristics of equine adult 
and foetal MSCs; in particular, MSCs derived from bone marrow and umbilical cord blood, 
and adipose tissue and Wharton’s jelly. 
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Materials and Methods 
Unless otherwise indicated, chemicals were purchased from Sigma-Aldrich, and laboratory 
plastics from Sarstedt Inc. 
Foetal MSCs were collected, cultivated and analysed at the Laboratory of Biotechnology and 
Animal Reproduction (LRBA) of Department of Veterinary Medical Sciences (DIMEVET). 
Adult MSCs were collected and cultivated at the Translational Centre of Regenerative 
Medicine (TRM) of University of Leipzig, Germany; then the cells were analysed at LRBA. 
The Transmission Electron Microscopy (TEM) was performed for both foetal and adult MSCs 
at Department for Biomedical and Neuromotor Sciences, University of Bologna, Italy. 
Animals 
Umbilical cord blood (UCB) and Wharton’s jelly (WJ) samples (Figure 5.1) were recovered 
immediately after delivery from three healthy mares, housed at the Department of Veterinary 
Medical Sciences, University of Bologna, for attended delivery. Experimental procedures 
were approved by the Ethics Committee, University of Bologna (8134-X/10). The written 
consent was given by the owners to allow tissues recovery for research purposes. 
Bone marrow (BM) and adipose tissue (AT) samples were collected from three healthy horses 
at Translational Centre of Regenerative Medicine (TRM) of University of Liepizig, Germany. 
Bone marrow was collected according to standard surgical procedures. Briefly, the horses 
were sedated, the sternal region was prepared aseptically and following local anaesthesia, the 
sternum was punctured with an 11 G bone marrow aspiration needle and a sample was 
aspirated into a heparinised syringe. Subcutaneous adipose tissue and tendon tissue used for 
the tenogenic differentiation were collected via skin incision from the supragluteal region and 
the superficial digital flexor tendon, respectively. Samples were stored at room temperature 
and subjected to cell isolation within 4 h after collection. Tendon samples for the tenogenic 
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differentiation were aseptically collected from the same animals and immediately frozen at 
−80°C. 
 
Figure 5.1. Collection of Umbilical Cord Blood and Wharton’s Jelly. 
Cell isolation and Doubling method 
Samples were washed under flowing water and stored in D-PBS (Dulbecco’s Phosphatase 
Buffered Solution) added with antibiotics (100 iu/ml penicillin and 100 µg/ml streptomycin), 
at 4°C, until processing. In the lab, cells were isolated as previously described (Iacono et al., 
2012; Burk et al., 2013). Primary cells were plated in a 25 cm
2
 flask in Dulbecco’s Modified 
Essential Medium (D-MEM) F12 Glutamax® (Gibco) supplemented with 10% FBS (Gibco) 
and antibiotics and incubated in a 5% CO2 humidified atmosphere at 38.5°C. At ~80-90% of 
confluence, cells were dissociated by 0.25% trypsin, counted and plated at the concentration 
of 5x103 cells/cm2 as “Passage 1” (P1), and so on for the following passages. Calculation of 
cell-doubling time (DT) and cell-doubling numbers (CD) was carried out according to the 
formulae of Rainaldi et al. (1991). 
Adhesion and Migration Assays 
In order to define differences between adult and foetal MSCs, spheroid formation and 
migration test were performed. For adhesion assay, cells were cultured in ‘hanging drops’ 
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(5.000 cells/drop) for 24 h. Images were acquired by a Nikon Eclipse TE 2000-U inverted 
microscope. Spheroid areas were determined using ImageJ software Version 1.6. Starting 
from the binary masks obtained by Image J, the volume of each spheroid was computed using 
ReViSP (Bellotti et al., 2016), a software specifically designed to accurately estimate the 
volume of spheroids and to render an image of their 3D surface. 
To assess cell migration potential, a scratch assay was carried out, as previously described 
(Liang et al., 2007). The distances of each scratch closure were calculated by ImageJ, and the 
migration percentages were calculated as previously reported (Rossi et al., 2014). 
In vitro differentiation 
At P3, in vitro differentiation potential of cells towards osteogenic, adipogenic, chondrogenic 
and tenogenic lineages was studied. Cells (5x10
3
 cells ⁄cm2) were cultured under specific 
induction media (Table 5.1) and for tenogenic differentiation as described by Lovati et al. 
(2012). 
About the tenogenic induction, the equine trimmed fresh tendon was co-cultured with MSCs 
separately on the opposite sides of permeable transwell inserts divided by a 0.4 μm pored size 
membrane (Corning Costar, Cambridge, MA, USA). The co-culture system consisted of a 
polycarbonate transwell chamber, which can be inserted into the well of standard 6-well 
plates. MSCs at P3 were seeded on the bottom of 6-well culture plates at 500 and 1000 cells/ 
cm
2
 for 15 days of co-culture. Tendon fragments of 2 to 3 mm
3
 were seeded on the upper 
membrane (pore size of 0.4 μm) of the transwell chamber. This chamber was inserted into the 
well of the plate and 3 ml of control medium, without foetal serum, were added to cover both 
the upper tendon pieces (Figure 5.2). The transwell co-culture system prevented the migration 
of both tendon fragments and released tenocytes in the lower chamber. It also inhibited cell-
cell contact thanks to the physical separation between the upper and lower chambers, while 
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allowing exchange of the serum-free medium without growth factors and the diffusion of 
soluble factors between the two compartments due to the pored membrane. 
 
Figure 5.2. Tenogenic differentiation. 
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Adipogenic medium 
(7 days) 
(Iacono et al., 2012) 
Chondrogenic Medium 
(21 days) 
(Iacono et al., 2012)
 
Osteogenic Medium 
(21 days) 
(Mizuno and Hyakusoku, 
2003)
 
DMEM F12 
15% Rabbit Serum 
0.5 mM IBMX
a
 
(removed after 3 days) 
1 μM DXMb 
(removed after 6 days) 
10 µg/mL insulin 
- 0.2 mM indomethacin 
DMEM/TCM199 
1%  FBS 
6.25 µg/mL insulin 
50 nM AA2P
c
 
0.1 μM DXMb 
-10 ng/mL hTGFβ1d 
 
DMEM/TCM199 
10%  FBS 
50 µM AA2P
c
 
0.1 μM DXMb 
10 mM BGP
e 
 
 
 
Table 5.1. Specific induction media compositions.aIBMX: isobutylmethylxanthine, bDXM: 
Dexamethasone, cAA2P: Ascorbic Acid 2-Phosphate, hTGF: d human Transforming Growth Factor, 
e
BGP: Beta-Glycerophosphate. 
As negative control, an equal number of cells was cultured in expansion medium for each 
differentation. 
To cytologically evaluate differentiation, cells were fixed with 10% formalin at room 
temperature (RT) and stained with Oil Red O, Alcian Blue, Von Kossa and Aniline Blue for 
adipogenic, chondrogenic, osteogenic and tenogenic induction, respectively. Adult MSCs 
were stained also with Van Gieson. 
Immunocytochemistry (ICC) 
Cells at P3, cultured on ICC slides, were fixed with 4 % paraphormaldehyde (20 min at RT), 
then washed in phosphate buffer (PB). Cells were blocked in goat serum (10 %) for 1 h and 
incubated overnight with primary antibodies (Table 5.2), then they were washed in PB2 (PB + 
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0.2 % BSA + 0.05 % saponin) and incubated with anti-mouse- or anti-rabbit- FITC 
conjugated secondary antibodies for 1 h. Nuclei were then labelled with Hoechst 33342 for 
foetal-MSCs and DAPI for adult-MSCs. The excess of secondary antibody and Hoechst/DAPI 
were removed by three washes with PB2. Images of MSCs were obtained with a Nikon 
Eclipse E400 microscope, using the software Nikon NIS-Elements. 
Primary Antibody Dilution 
α-SMA (α-smooth muscle actin) 
(Gene tex) 
1:500 
N-Cadherin 
(Biorbyt orb11100) 
1:100 
Table 5.2. Primary antibodies for ICC. 
Molecular Characterization 
One hundred thousand cells were snap-frozen and RNA was extracted using Nucleo Spin® 
RNA kit (Macherey-Nagel) following the manufacturer’s instructions. cDNAs were 
synthesized by RevertAid RT Kit (ThermoFisher Scientific) and used directly in PCR 
reactions, following the instructions of Maxima Hot Start PCR Master Mix (2X) 
(ThermoFisher Scientific). The primers used are listed in Table 5.3. PCR products were 
visualized with ethidium bromide on a 2% agarose gel.  
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Primers References Sequences (5′→3′) bp 
MSC marker 
   
CD90 Mohanty et al., 2014 FW: TGCGAACTCCGCCTCTCT 
93 
  
RW: GCTTATGCCCTCGCACTTG 
CD73 Mohanty et al., 2014 
FW: GGGATTGTTGGATACACTTCAAAAG 
RW: GCTGCAACGCAGTGATTTCA 
90 
Ematopoietic 
markers    
CD34 Mohanty et al., 2014 FW: CACTAAACCCTCTACATCATTTTCTCCTA 
101 
  RW: GGCAGATACCTTGAGTCAATTTCA 
CD45 Mohanty et al., 2014 FW: TGATTCCCAGAAATGACCATGTA 
101 
  
RW: ACATTTTGGGCTTGTCCTGTAAC 
MHC markers 
   
MHC-I Corradetti et al., 2011 FW: GGAGAGGAGCAGAGATACA 
218 
  RW: CTGTCACTGTTTGCAGTCT 
MHC-II Corradetti et al., 2011 FW: TCTACACCTGCCAAGTG 
178 
  
RW: CCACCATGCCCTTTCTG 
ILs 
   
TNF α Jischa et al., 2008 FW: GCTCCAGACGGTGCTTGTG 
95 
  RW: GCCGATCACCCCAAAGTG 
IL-8 Jischa et al., 2008 FW: CGGTGCCAGTGCATCAAG 
81 
  RW: TGGCCCACTCTCAATCACTCT 
INF-γ Castagnetti et al., 2012 FW: GTGTGCGATTTTGGGTTCTTCTA 
235 
  RW: TTGAATGACCTGGTTATCT 
IL4 Castagnetti et al., 2012 FW: CAACTTCATCCAGGGATGCAA 
107 
  RW: CAGTCAGCTCCATGCACGAAT 
IL-β1 Castagnetti et al., 2012 FW: GAGGCAGCCATGGCAGCAGTA 
257 
  RW: TGTGAGCAGGGAACGGGTATCTT 
IL-6 Visser and Pollitt, 2011 FW: AAACCACCTCAAATGGACCACTA 
91 
  
RW: TTTTTCAGGGCAGAGATTTTGC 
Pluripotency 
markers    
OCT4 Desmarais et al., 2011 FW: TCCCAGGACATCAAAGCTCTGCAGA 
679 
  RW: TCAGTTTGAATGCATGGGAGAAGCCCAGA 
NANOG Desmarais et al., 2011 FW: GACAGCCCCGATTCATCCACCAG 
492 
  RW: GCACCAGGTCTGACTGTTCCAGG 
SOX2 Desmarais et al., 2011 FW: GGCGGCAACCAGAAGAACAG 
663 
  
RW: AGAAGAGGTAACCACGGGGG 
Housekeeping 
   
GAPDH Desmarais et al., 2011 FW: GTCCATGCCATCACTGCCAC 
262 
  RW: CCTGCTTCACCACCTTCTTG 
Table 5.3. Sequence of primers used for PCR analysis. 
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Transmission Electron Microscopy (TEM) 
Equine MSCs at P3 obtained from UCB, WJ, AT and BM were fixed with 2.5% 
glutaraldehyde in 0.1 M cacodylate buffer for 2 h and post fixed with a solution of 1% 
osmium tetroxide in 0.1 M cacodylate buffer. The cells were then embedded in epoxy resins 
after a graded-ethanol serial dehydration step. The embedded cells were sectioned into 
ultrathin slices, stained by uranyl acetate solution and lead citrate, and then observed with 
transmission electron microscope CM10 Philips (FEI Company, Eindhoven, The Netherlands) 
at an accelerating voltage of 80 kV. Images were recorded by Megaview III digital camera 
(FEI Company, Eindhoven, The Netherlands). The TEM analysis was performed at 
Department for Biomedical and Neuromotor Sciences, University of Bologna, Italy. 
Statistical Analysis 
Harvested WJ, UCB, BM and AT (grams), CDs, DTs and percentages of migration are 
expressed as mean ± standard deviation (SD). Statistical analyses were performed using IBM 
SPSS Statistics 21 (IBM Corporation). Data were analysed, for normal distribution, using a 
Shapiro-Wilk test, and then using one-way ANOVA. The 3D spheroid volumes and mean 
gray intensity of differentiated cells were compared using Bonferroni’s test. Significance was 
assessed for P<0.05. 
Results 
Cell isolation and Doubling method 
Adherent mononuclear cells were characterized by a homogeneous elongated fibroblast-like 
morphology. Undifferentiated cells of both lines were passaged up to three times; no changes 
in cell morphology was observed throughout the culture period. 
Results were reported in Table 5.4. No statistically significant differences were found in DTs 
among earlier culture passages in both cell lines (P>0.05). 
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CD DT 
UCB 9.6 ± 0.9 2.4 ± 1.3 
WJ 9.9 ± 1.1 2.693 ± 0.9 
BM 8.6 ± 0.4 3.6 ± 1.4 
AT 9.0 ± 1.4 2.2 ± 1.1 
Table 5.4. Cell-doubling numbers (CD) and cell-doubling time (DT) reported as mean ± sd. 
 
Adhesion and Migration Assays 
Both foetal and adult MSCs formed spheroids when cultured in hanging drops (Figure 5.3). 
Average areas and volume of the spheroids formed by foetal MSCs (derived from WJ and 
UCB) were significantly smaller than from adult MSCs (derived from BM and AT; P<0.05).  
Average percentage of migration, observed by scratch test, was statistically similar between 
cell lines (WJ-MSCs: 43.04±7.74% vs UCB-MSCs: 28.36±5.01% vs BM-MSCs: 
25.02±10.20% vs AT-MSCs: 24.48±21.44%; P>0.05). 
 
Figure 5.3. Spheroids of MSCs derived from BM, AT, WJ and UCB performed with ReViSP. 
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In vitro differentiation 
All cell lines were able to differentiate toward osteogenic (Figure 5.4), chondrogenic (Figure 
5.5), adipogenic (Figure 5.6) and tenogenic direction (Figure 5.7 and 5.8).
 
Figure 5.4. Osteogenic induction in UCB (a), WJ (b), BM (c) and AT-MSCs (d) over three weeks: von 
Kossa staining of extensive extracellular calcium deposition. 
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Figure 5.5. Chondrogenic induction in UCB (a), WJ (b), BM (c) and AT-MSCs (d) over three weeks: 
Alcian Blue staining of glycosaminoglycans in cartilage matrix. 
 
Figure 5.6. Adipogenic induction in UCB (a), WJ (b), BM (c) and AT-MSCs (d) over one week: Oil 
red O staining of extensive intracellular lipid droplet accumulation. 
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Figure 5.7. Tenogenic differentiation and staining with Aniline Blue method. UCB-MSCs control cells 
(a) and differentiated cells (b), WJ-MSCs control cells (c) and differentiated cells (d), BM-MSCs 
control cells (e) and differentiated cells (f) and AT-MSCs control cells (g) and differentiated cells (h). 
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BM-MSCs and UBC-MSCs showed the greater tenogenic potential; AT-MSCs showed an 
intermediate potential and WJ-MSCs showed the lower one. 
 
Figure 5.8. Tenogenic induction in AT-MSCs (a: magnification 10x; b: magnification 40x), BM-MSCs 
(c: magnification 10x; d: magnification 40x) over two weeks: Van Gieson staining. 
 
Phenotypic and Molecular Analysis by Immunocytochemistry and PCR 
Data observed by immunocytochemical staining of foetal and adult MSCs are showed in 
Table 5.5. Both cell lines clearly expressed the mesodermal marker alpha-SMA (Figure 5.9 a, 
c, e, g). On the contrary, UCB and BM- MSCs did not express the mesenchymal marker N-
Cadherin (Figure 5.9 b, d, f, h). Data obtained by PCR were reported in Table 5.6. 
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α-SMA N-Cadherin 
UCB + - 
WJ + + 
BM + - 
AT + + 
Table 5.5. Result about the expression of alpha-SMA and N-Cadherin in foetal and adult MSCs. 
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Figure 5.9. Photomicrographs of immunostaining of UCB, WJ, BM and AT-MSCs. Expression of the 
mesenchymal marker alpha-SMA in the UCB (a), WJ (c), BM (e) and AT-MSCs (g). Expression of the 
mesodermal marker alpha-SMA in the UCB (a), WJ (c), BM (e) and AT-MSCs (g). Expression of the 
mesenchymal marker N-Cadherin in the UCB (b), WJ (d), BM (f) and AT-MSCs (h). 
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Molecular Characterization 
Primers WJ-MSCs UCB-MSCs 
BM-
MSCs 
AT-
MSCs 
MSC marker     
CD90 + + +  + 
CD73 + - + - 
Ematopoietic markers     
CD34 + - - - 
CD45 - - - - 
MHC markers     
MHC-I + + + + 
MHC-II - - - - 
ILs     
TNF α - - - - 
IL-8 + - - - 
INF-γ - - - - 
IL4 - - - - 
IL-β1 + - - - 
IL-6 + - - - 
Pluripotency markers     
OCT4 + - - - 
NANOG - - - - 
SOX2 - - - - 
Table 5.6. Results obtained by PCR running on foetal and adult MSCs. 
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Transmission Electron Microscopy (TEM) 
Equine MSCs, obtained from umbilical cord blood, showed a fibroblast shape morphology 
with the nucleus and few nucleolus clearly detectable (Figure 5.10A). Localized in specific 
areas of the cytoplasm, several organelles such as Golgi apparatus surrounded by several 
vesicles (Figure 5.10B), rough endoplasmic reticulum (RER) (Figure 5.10C) and long 
mitochondria (Figure 5.10D) were well preserved and easily identified. Moreover, 
multivesicular bodies (Figure 5.10B) and lipid droplets (Figure 5.10A and Figure 5.10B) 
were observed in the cytoplasm. MSCs obtained from equine Wharton’s jelly appeared with a 
spindle like morphology (Figure 5.10E) with the nucleus and nucleolus easily detectable 
(Figure 5.10E). At higher magnification, a regular RER and Golgi apparatus were observed 
(Figure 5.10F and Figure 5.10G). Several mitochondria with a long shape morphology and 
lipid droplets appeared widespread in the cytoplasm (Figure 5.10E and Figure 5.10H). MSCs 
collected from equine bone marrow showed a fibroblast like morphology comparable to the 
cells obtained from embryonal annexes tissues (Figure 5.11A). The cytoplasm was 
characterized by the presence of a widespread Golgi apparatus surrounded by several small 
vesicles (Figure 5.11B) and multivesicular bodies (Figure 5.11B insert). An extensive RER 
with enlarged membrane free from ribosomes and elongated mitochondria were well detected 
(Figure 5.11C) in the cytoplasm. Several cluster of extracellular vesicles and exosomes were 
observed on cell membrane (Figure 5.11D). MSCs collected from equine adipose tissues 
showed a well preserved morphology, with an elongated spindle body comparable to the cells 
obtained from equine bone marrow (Figure 5.11E). Golgi apparatus was widespread in the 
cytoplasm and several vesicles, organized in multivesicular bodies, were observed (Figure 
5.11F). RER showed enlarged membranes almost free from ribosomes (Figure 5.11G). 
Several extracellular vesicles and exosomes were localized on the cell membrane (Figure 
5.11H). 
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Figure 5.10. TEM analysis of equine UCB-MSCs. (A) cells showed a spindle morphology (N: nucleus; 
n: nucleolus; arrowhead: lipid droplets) (magnification 1950X; bar: 10um); (B) the Golgi apparatus 
(arrow) surrounded by several vesicles and multivesicular bodies (white arrowheads) are observed 
(magnification: 13500X; bar: 1um); (C) cytoplasmic area showing a regular RER (*) (magnification: 
13500X; bar: 1um); (D) Elongated mitochondria with evident internal cristae (m) (magnification: 
19000X; bar: 500nm). TEM analysis of equine WJ-MSCs. (A) cells showed a fibroblast like 
morphology (N: nucleus; n: nucleolus; arrowheads: lipid droplets) (magnification 1950X; bar: 
10um); (B) cytoplasmic area showing a regular RER (*) (magnification: 13500X; bar: 1um); (C) the 
Golgi apparatus (arrow) surrounded by several vesicles (N: nucleus; n: nucleolus; arrowheads: lipid 
droplets) (magnification: 13500X; bar: 1um); (D) Elongated mitochondria with regular  internal 
cristae (m) (magnification: 19000X; bar: 500nm).  
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Figure 5.11. TEM analysis of equine BM-MSCs. (A) cells showed a fibroblast like morphology (N: 
nucleus; n: nucleolus) (magnification 1100X; bar: 20um); (B) the Golgi apparatus (arrow) 
surrounded by several vesicles (insert; magnification: 13500X; bar: 1um) are observed 
(magnification: 13500X; bar: 1um); (C) cytoplasmic area showing an enlarged RER (*) almost free 
from ribosomes (magnification: 19000X; bar: 500 nm); (D) exosomes (black arrows) clustered on cell 
membrane, extracellular vesicles (arrowheads) and elongated mitochondria (m) are detected 
(magnification: 13500X; bar: 1um). TEM analysis of equine AT-MSCs. (E) the cells showed a 
fibroblast like morphology (N: nucleus; n: nucleolus) (magnification 1450X; bar: 10um); (F) the 
Golgi apparatus (arrow) surrounded by several vesicles (magnification: 13500X; bar: 1um) is 
observed; (G) the cytoplasmic area showing RER with dilated membranes (*) (magnification: 
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13500X; bar: 1um); (D) exosomes (black arrow) clustered on cell membrane (magnification: 19000X; 
bar: 500nm). 
Discussion 
In this study, MSCs from foetal (UCB and WJ) and adult tissue (BM and AT) were isolated 
and many features were compared: proliferation, migration, spheroids formation, 
differentiation capacity, expression of stemness markers, immunophenotype and 
ultrastructural features. Both foetal and adult MSCs were isolated, cultivated with standard 
protocols and they did not show statistical differences for CD and DT; however, in this study 
we considered only the first three passages of culture. All isolated cells showed the typical 
mesenchymal morphology. No differences were found between foetal and adult MSCs in 
migration ability. 
At P3 all cells were differentiated to evaluate their osteogenic, chondrogenic and adipogenic. 
For the first time in equine species, cells from foetal adnexa were differentiated toward 
tenogenic line. Since the adhesion capability is related and enhanced to chondrogenic 
differentiation potential (Wang et al., 2009; Kavanagh et al., 2014; Sart et al., 2014), in the 
present study, the spheroid formation capability in vitro was assessed using the hanging drop 
method. Furthermore, the spheroids volume were determined by ReVisp (Bellotti et al., 
2016). Cells derived from WJ showed a higher adhesion ability, forming smaller spheroids. 
Cells derived from umbilical cord blood were not able to give origin to a unique spheroid; in 
fact, they always create multiple small spheroids. According to these findings and to previous 
studies (Wang et al., 2009; Kavanagh et al., 2014; Sart et al., 2014), WJ-MSCs showed the 
highest chondrogenic and osteogenic differentiation potential, related to UCB-MSCs and 
adult cells. On the contrary, cells isolated from fluid matrix (BM and UCB) showed a higher 
ability to differentiate in tenocytes, while WJ-MSCs showed the lower one. It’s still not clear 
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if this minor differentiation potential is due to a not suitable tenogenic induction protocol or 
because cells are not enough stimulated. 
ICC investigation showed in all cell lines a positive expression of the mesodermal marker 
alpha-SMA. However, the ICC results regarding the expression of N-Cadherin by cells 
derived from fluid matrix (UCB and BM) are controversial: in fact, these cells presented a 
low expression of this typical mesenchymal marker. Further investigation on other samples 
are therefore necessary. 
Regarding molecular analysis, foetal and adult MSCs at P3, demonstrate the characteristics 
defined by the International Society for Cellular Therapy (Dominici et al., 2006). Excepting 
for WJ-MSCs, all cells line resulted negative for CD34. As recently demonstrated, the 
expression of CD34 seems to depend on the environment, on the in vitro culture cell passages 
(Lin et al., 2012) and on the cell source. Furthermore, WJ-MSCs were the unique that 
expressed OCT-4, IL-8, IL-β1 and IL-6. The OCT-4 is a typical marker of embryonic 
pluripotent cells (Miki et al., 2005; Izumi et al., 2009; De Coppi et al., 2007; Pirjali et al., 
2013; Shaer et al., 2014) and it should not be expressed by MSCs. However, its expression, 
associated with the high differentiative potential of WJ-MSCs give them an intermediate 
characteristic between foetal and embryonic. IL-1β, IL-6 and IL-8 are important mediator of 
the inflammatory response, involved in a variety of cellular activities, including cell 
proliferation, differentiation, apoptosis, chemotaxis, angiogenesis and hematopoiesis 
(Lamalice et al., 2007). These factors are involved in the complex interaction between MSCs 
and the tissue microenvironment as well as production of membrane vesicles, containing 
molecules such as short peptides, proteins, lipids, and various forms of RNAs (György et al., 
2011). Their expression by WJ-MSCs make these cells the best choice for the application in 
regenerative medicine, also for the non-invasive collection of WJ. In fact, umbilical cord is 
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routinely discarded at parturition, and in our study no side effects for mare and foal were 
observed. Furthermore, at RT-PCR, all the cells resulted negative to TNF-α, IL-4 and INF, 
cytokines produced only after in vitro stimulation (De Schauwer et al., 2014). 
All cells derived from all sources at TEM showed an elongated spindle body, a characteristic 
morphology of mesenchymal stem cells. 
In adult equine cells, it was reported that the great number of vacuolar bodies that, actually, 
were not empty but contained small, medium and large intraluminal vesicles maturing from 
their internal membrane, might be interpreted as the ability of both cell types to produce a 
huge variety of “secreting” molecules (Pascucci et al., 2014). In this study as well, numerous 
intra and extracellular vacuolar bodies in foetal MSCs were found. These vesicles, originated 
from the internal layer of the cell membrane, had different dimensions (small, medium and 
big), containing a material of unknown composition. As demonstrated by other authors, they 
have the role of collecting efficiently cellular components: since cells have an intense 
replicative and metabolic capacity, they continuously need a renovation of their structures. 
Recent studies support the idea that these microvesicles contain some substances, made by the 
cell itself, that have a fundamental role in stimulating healing processes in damaged tissues 
(Du et al., 2014; Lange-Consiglio et al., 2016), and have also immunomodulatory activities 
(Aliotta et al., 2012). 
At the present day, they are subject of many studies because it is thought that they have 
communication roles between cells: releasing their content, they provide lipids, proteins and 
mRNa/microRNA to damaged cells, helping the restore of their integrity (Simons et al., 2009; 
Camussi et al., 2010; Gyorgy et al., 2011). 
In this study in AT and BM-MSCs, intracellular vesicular bodies were not found, but Bruno et 
al. (2013) reported that these are present in human BM-MSCs. MVs have a membrane, and 
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they have to be released in the extra cellular space in order to play their role, so they can 
bound to target cells using a specific receptor (Bruno et al., 2009). Once they have released 
their content, it is dispersed into the culture medium: if damaged cells are put in this 
“conditioned” culture medium, it is evident how it plays a therapeutic role on them, acting in 
a paracrine way (Bi et al., 2007). In the present study, we observed extracellular vesicles in 
BM-MSCs. 
Even if there is a lot of interest for microvescicles, a lot has to be discovered, so further 
studies are necessaries especially in equine medicine, in order to confirm their role in healing 
and immunomodulatory processes and their possible use in regenerative medicine. 
In conclusion, it seems that foetal MSCs, especially WJ-MSCs, are the best source of stem 
cells in comparison with adult MSCs thanks to their characteristics. In particular, as for 
human also for the equine species, the cellular banking for Wharton’s Jelly, as Mesenchymal 
Stem cells niche, could be very useful. Both in human and equine species, mesenchymal stem 
cells (MSCs) from perinatal tissue, primarily Wharton’s jelly (WJ), may be particularly useful 
in the clinic for autologous transplantation for newborns and after banking in later stages of 
life.   
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SECTION III-   Clinical Application 
 
CHAPTER 6 
EFFECTS OF AMNIOTIC FLUID MESENCHYMAL STEM CELLS IN 
CARBOXYMETHYL CELLULOSE GEL ON HEALING OF 
SPONTANEOUS PRESSURE SORES: CLINICAL OUTCOME IN 
SEVEN HOSPITALIZED NEONATAL FOALS. 
Iacono E., Lanci A., Merlo B., Ricci F., Pirrone A., Antonelli A., Mariella J., Castagnetti C. 
Turkish Journal of Biology (2016) 40:484-492 
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CHAPTER 7 
EFFECTS OF WHARTON’S JELLY MESENCHYMAL STEM CELLS 
ON PRESSURE SORE OF A SIX-MONTH-OLD FILLY 
Article in Preparation 
Department of Veterinary Medical Sciences, University of Bologna, Ozzano Emilia, Bologna, Italy 
Introduction 
Wounds are common in equine patients as a consequence of physical overstrain, and could 
negatively affects quality of life and athletic performance (Dart et al., 2005). Both equine and 
human persistent or slow healing injuries are a challenge for clinicians. These lesions 
frequently result in inadequate tissue reorganization and thus in a high re-injury rate and are 
related to a long period of incapacity or to an unsatisfactory return to performance. 
The repair of full-thickness cutaneous wounds depends principally on three coordinated and 
overlapping phases: acute inflammation, cellular proliferation, and finally matrix synthesis 
and remodeling with scar formation (Theoret, 2004). The first phase prepares the wound for 
the subsequent reparative phases with the involvement of cells, such as neutrophils and 
macrophages, and mediators, such as cytokines and growth factors. If this phase is not 
resolved quickly, the persistence of inflammatory cells and mediators might contribute to the 
pathogenesis of diseases characterized by excessive fibrosis and/or scarring. The proliferation 
stage involves fibroblast migration and growth with the formation of granulation tissue and 
epithelialization (Theoret, 2004). The final phase determines the reduction of wound size by a 
process referred as “wound contraction” that it is due to a contractile phenotype of fibroblasts. 
Collagen remodelling with the formation of larger bundles, oriented along the lines of tension, 
ensures an increase in tensile strength during this last phase (Theoret, 2004). 
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Enormous variation exists in treatments, medications, bandages, and bandaging techniques 
applied to wounds in horses (Dart et al., 2005; Stashak and Theoret, 2008). In the last few 
years, different research groups reported good results in the skin healing using MSCs, both in 
human and veterinary medicine. In the present study, a 6 months old foal, with a skin wound 
on the left hock, was treated with local application of heterologous WJ-MSCs in autologous 
plasma, and the wound’s regression was determined. 
Case history and clinical findings 
A 45 kg Standarbred filly was born in April 2016 at the Equine Perinatology Unit (EPU) 
“Stefano Belluzzi” - Department of Veterinary Medical Sciences (DIMEVET) - University of 
Bologna. The delivery was eutocic and the foal’s APGAR score at birth was 10 (Vaala, 2006). 
At birth, the filly had severe flexural/angular deformity of the hind limbs (Figure 7.1a) and 
she was unable to stand up and to suckle; for this reason, she was fed with nasogastric tube 
for the first 24 hours. At one-day of life she was able to stand up and nurse but she spent long 
periods in decubitus, and at 3 days of life a superficial pressure sore appears on the left hock 
(Figure 7.1b). Before starting treatments, Sessing classification (Ferrell et al., 1995; Table 
7.1) and National Pressure Ulcer Advisory Panel (NPUAP; Bluestein and Javaheri, 2008; 
Table 7.2) criteria, usually employed in human medicine, were applied to determine the 
severity of the pressure sore. In particular, Sessing classification is usefull to classify sores 
according to macroscopic appearance, while NPUAP criteria are applied to evaluate the depth 
degree. According to Sessing classification, skin sore was grade 4, while in the NPUAP 
classification it corresponded to grade 3. The wound was washed with sterile water, 
medicated with hyaluronic acid in gauze (Connettivina®; Fidia farmaceutici S.p.A., Italy) and 
bandaged with cotton gauze, bandage and Vetrap (3m, Milan, Italy) every day until discharge. 
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At discharge the wound, according to Sessing classification, was grade 3, while in the 
NPUAP classification it corresponded to grade 2 (Figure 7.1c). 
 
Figure 7.1. a) filly at 2 days of life; b) the wound at 3 days of life; c) the wound at discharge at 10 
days of life. 
As referred by the owner, the wound, treated with ozone therapy at stud farm, healed 
completely on June at 2 months of life (Figure 7.2). However, the owner referred that the filly 
spent long period in decubitus also at the farm until August. 
 
Figure 7.2. a) at the beginning of the treatment with ozone therapy; b) in the middle and c) at the end. 
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At the end of September, the 6 months old filly was admitted at EPU because the owner 
referred that in July a wound in the same left hock appeared again. At admission, the wound, 
according to Sessing classification was grade 5, while in the NPUAP classification it 
corresponded to grade 4 (Figure 7.3). 
Stage Description 
0 Normal skin, but at risk. 
1 Intact skin, but hyperpigmented or reddened. 
2 The bottom and edges of the ulcer are intact and not red. 
3 
The bottom and edges of the ulcer with pink granulation tissue, modest 
presence of exudate and odor. 
4 
Presence of modest granulation tissue, initial and modest necrotic tissue, 
moderate exudate and odor. 
5 
Abundant presence of foul smelling exudate, necrotic eschar, and whitish or 
reddish edges. 
6 
Further ulceration around the primary ulcer, purulent exudate, intense odor, 
presence of necrotic tissue and systemic symptoms of sepsis. 
Table 7.1. Sessing classification of skin wounds (Ferrell et al., 1995). 
Stage Description 
1 
Intact skin with nonblanchable redness of a localized area usually over a 
bony prominence. Darkly pigmented skin may not have visible blanching; its 
color may differ from the surrounding area. The area may be painful, firm, 
soft, warmer, or cooler as compared to adjacent tissue 
2 
Partial thickness loss of dermis presenting as a shallow open ulcer with a red 
pink wound bed, without slough. May also present as an intact or 
open/ruptured serum-filled or serosanguineous filled blister. Presents as a 
shiny or dry shallow ulcer without slough or bruising. 
3 
Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon, 
or muscle are not exposed. Slough may be present but does not obscure the 
depth of tissue loss. May include undermining and tunneling. 
4 
Full thickness tissue loss with exposed bone, tendon, or muscle. Slough or 
eschar may be present. Often includes undermining and tunneling. The ulcer 
can extend into muscle and/or supporting structures (e.g., fascia, tendon, or 
joint capsule), making osteomyelitis or osteitis likely to occur. Exposed 
bone/muscle is visible or directly palpable. 
Table 7.2. Classification of the National Pressure Ulcer Advisory Panel (NPUAP; Bluestein and 
Javaheri, 2008). 
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Figure 7.3. The wound at admission in September. Wound’s area was 4.73±0.15 cm2. 
Treatment 
The treatment was divided into three phases: 
Surgical phase 
Since the skin and subcutaneous tissue appeared necrotic, before starting the Mesenchymal 
Stem Cells (MSCs) treatments, a surgical courettage was carried out. Under sedation, the 
depth of the wound was evaluated with sterile stylet and a deep surgical curettage was carried 
out with sterile scalpel to remove the necrotic tissue (Figure 7.4 a). The wound was cleaned 
with sterile water, medicated with salicylic acid powder and bandaged. For the following 8 
days the wound was daily washed with tap water, mechanical debridement was performed 
using a woven wet gauze and Dermaflon
®
 (salicylic acid, malic acid, benzoic acid; Zoetis, 
Italy) was applied on the wound. The surgical curettage was repeated at Day 5 (at fifth day 
after admission). At Day 8 the wound’s area was 7.28±0.20 cm2 (Figure 7.4 f). 
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Figure 7.4. First period of treatment: surgical courettage and Dermaflon
®
 for deep debridement of 
the wound. a) The wound during first surgical curettage at Day 0; b) The wound at Day 3; c) The 
wound at Day 4; d) The wound at Day 5; e) The wound at Day 7; f) The wound at Day 8, area was 
7.28±0.20 cm
2
: time of first application of WJ-MSCs. 
 
Regenerative phase 
At Day 8, the wound was grade 4 according to Sessing classification, while in the NPUAP 
classification it corresponded to grade 4. It had less granulation tissue and little necrotic flesh. 
Four cutaneous applications of MSCs were performed in 18 days, within about 4 days of each 
other. 
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Mesenchymal stem cell isolation and culture 
The employed MSCs were collected in the foaling season 2016 from Wharton’s jelly 
(Figure 7.5); the cells were isolated and cultured until Passage 2 (P2) of culture. At P2 
the cells were cryopreserved in liquid nitrogen. 
Before the cutaneous application, WJ-MSCs were thawed (P3) and re-expanded in 
Dulbecco’s Modified Essential Medium (D-MEM) F12 Glutamax® (Gibco). Then 
immunophenotypic characterization was performed, testing the following markers: the 
cells resulted positive for CD90, and negative for CD45 and mycoplasma by RT-CPR. 
  
Figure 7.5. WJ-MSCs at P2. 
Staging of preparations for MSC application 
Immediately before application, under a laminar flow hood and in sterile conditions, 
WJ-MSCs were detached from the flask and cells were counted using a hemocytometer. 
For each application, approximately 5 × 10
5
 cells/mL were used. Autologous plasma 
was collected with sterile closed system from the filly. A gel of CMC used as a scaffold 
was produced in a sterile petri dish under a laminar flow hood using 5 g of CMC and 5 
mL of autologous plasma. Before preparing gel, the CMC was placed for 30 min under 
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a UV lamp to avoid bacterial contamination. Immediately before treatment, cells were 
added to the gel. 
Before applying MSCs, wounds were rinsed with isotonic sterile saline solution. The 
skin around the wounds was greased with Vaseline to prevent further damage at the 
time of the next dressing. Immediately after application, the limb was bandaged with 
cotton gauze, a bandage, and Selfix (Pic solution, Artsana S.p.A., Italy) (Figure7.6c). 
 
After the first application, at Day 12 (Figure7.6 d) the wound’s area was 4.25±0.03 cm2 and it 
was grade 3 according to Sessing classification because there was an odorless yellow exudate, 
while in the NPUAP classification it corresponded to grade 2. 
After the four applications, at Day 22 (Figure7.6 g), the wound’s area was 1.90±0.03 cm2 and 
it was grade 2 according to Sessing classification, while in the NPUAP classification it 
corresponded to grade 2. 
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Figure 7.6. Second period of treatment: cutaneous application of Mesenchymal Stem Cells derived 
from Wharton’s Jelly. a) WJ-MSCs in gel of autologous plasma and carboxymethyl cellulose. b) 
Application of WJ-MSCs gel. c) Bandage. d) Day 12, the wound after the first application of WJ-MSCs 
and the area was area was 4.25±0.03 cm
2
. e) Day 14, the wound after the second application of WJ-
MSCs and the area was area was 4.07±0.04 cm
2
. f) Day 19, the wound after the third application of 
WJ-MSCs and the area was area was 2.53±0.06 cm
2
. g) Day 22, the wound after the fourth 
application of WJ-MSCs and the area was area was 1.90±0.03 cm
2
. 
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Medical phase 
In this phase, the wound had abundant granulation tissue, wound’s sizes were modest, and the 
wound was superficial. 
The wound was daily cleaned and treated by hydrotherapy with cold tap water for 10 minutes 
and application with RHD
® 
cream (hyperozonized lipids; Acme s.r.l., Italy) and Vaseline on 
skin around the wound. Immediately after application, the limb was bandaged with cotton 
gauze and Selfix (Pic solution, Artsana S.p.A., Italy; Figure 7.7). 
S E C T I O N  I I I -    C l i n i c a l  A p p l i c a t i o n | 153 
 
 
Figure 7.6. Third period of treatment: daily hydrotherapy and application of RHD
®
. a) Cutaneous 
application of ointment RHD
®
. b) Day 26, area was 1.67±0.04 cm
2
. c) Day 32, area was 0.97±0.01 
cm
2
. d) Day 34, area was 0.78±0.02 cm
2
. e) Day 36, area was 0.59±0.01 cm
2
. f) Day 39, day of 
discharge, area was 0.38±0.01 cm
2
. 
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The wound was photographed using a digital camera at every treatment (T0 = day at the 
hospitalization and Td = day at discharge). A ruler was placed next to the wound as a 
reference. Images of the wounds were analyzed using image analysis software (ImageJ, 
processing and analysis in Java, Version 1.6). The area (cm
2
) was measured three times and 
the average was calculated to obtain a single measure. The line for measurement was drawn 
along the margin of the epithelium granulation, leaving scar tissue (Figure 7.8). 
At the end of each phase, the mean percentage of regression was calculated as follows: 
% of regression = (A – a x 100) /A, 
Where A is the initial Area and a is the same area measured at the end of the phase of 
treatment (Table 7-3). 
 
Figure 7.8. Measure of wound’s area using software ImageJ. 
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Outcome  
At Day 39 the wound’s area was 0.38±0.01 cm2 (Figure 7.7f). 
 
Graph 1. Regression of wound’s area (cm2) in 39 days of hospitalization. 
 
Phase of treatment Wound’s Area (cm2) % of regression 
Day 0 4.73±0.15 / 
Sugical phase 7.28±0.20 -54% 
Regenerative phase 1.90±0.03 + 74% 
Medical phase 0.38±0.01 + 80% 
Table 7.3. Percentage of regression of each phase of the treatment. 
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As shown by the photos sent by the owner, the hair grew completely without changing color 
of the coat and did not leave evident scars on the skin (Figure 7.9). 
 
Figure 7.9. Day 47. Picture sent by the owner 8 days after discharge. 
 
Discussion 
Wound infection and the development of chronic inflammation leading to ulcerative-type 
lesions, as well as fibro-proliferative conditions such as exuberant granulation tissue, are 
frequent in wounds occurring in horse limbs (Theoret, 2008). It is reported that 7% of injuries 
leading to the retirement of racehorses are the direct result of a wound (Perkins et al., 2005). 
Wounds, particularly on the distal limb, are a common occurrence in horses and, when they 
involve structures underlying the skin, are costly and time-consuming to manage and may 
lead to decreased performance, retirement or euthanasia (Theoret et al., 2016). 
Several factors influence wound healing as wound type, degree of contamination, location and 
age of the wound. Wound type is an important indicator of the vascular supply, degree of 
contamination, and viability of surrounding tissue, which reliably determine the best mode of 
management. The inflammatory phase is prolonged in the presence of necrotic debris, foreign 
material, or infection. Distal limb wounds are the most difficult to heal because the skin has a 
decreased vascular supply, numerous bony prominences, absence of supporting deep 
S E C T I O N  I I I -    C l i n i c a l  A p p l i c a t i o n | 157 
 
musculature, highly mobile joints, and a generally higher degree of contamination than in 
other body sites (Moy, 1993; Cochrane et al,. 2003; Knottenbelt, 2003). There are many 
sources of chronic inflammation in a wound, including necrotic tissue, foreign bodies, 
repetitive mechanical trauma, and the application of cytotoxic agents (Knottenbelt, 2003). 
Furthermore, chronic wounds do not progress normally through the various phases of repair, 
usually because of underlying conditions. The goal of chronic wound therapy is to identify 
and resolve the causal factors so that healing could proceed (Knottenbelt, 2003; Hendrickson 
and Virgin, 2005). 
Necrotic tissue and foreign bodies prolong inflammation because of the body’s attempt to rid 
the area of the alien matter. Debridement of devitalized tissue is the most effective method to 
improve healing in these cases. 
The new epithelium, which eventually covers a wound healing by second intention, is fragile 
and susceptible to reinjury so that wound contraction is considered a mechanism to reduce the 
wound surface area (Theoret, 2004). In the present study, the filly was hospitalized for a re-
injury of a pressure wound, probably due to the newly formed thin skin. When the filly was 
readmitted in September, she did not spend too much time in decubitus; the stimulating 
pressure due to the frequent recumbences was no longer present. 
Wound assessment is one of the most important step in wound repair: the failure of a 
regenerative process is at the basis of an erroneous assessment and the beginning of an 
inappropriate treatment (Hendrickson, 2012). In this case, at first evaluation of the wound, our 
group decided to start with accurate debridement because the necrotic tissue was very 
abundant. Debridement is an effective way to reduce the bacterial contamination and to 
minimize necrotic tissue. The most common type of debridement in equine practice is surgical 
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and other types of debridement (mechanical and autolytic) tend to create more trauma, 
consequently increasing the healing time required (Hendrickson, 2012). 
In the present study, a surgical debridement was associated with a mechanical one to permit a 
complete removal of necrotic tissue and to create a perfect wound bed for MSCs’ application. 
The debridement phase led to an increase of 54% of the size of the wound in 8 days. 
In the regenerative phase of the treatment, we performed four cutaneous applications of WJ-
MSCs in carboxymethylcellulose gel, as a scaffold, and autologous plasma, as metabolic 
support for the cells. 
Since long time, in human medicine it has been shown that MSCs can differentiate not only 
into mesenchymal lineage cells but also into other lineage cells in vitro, while in vivo studies 
have also shown that MSCs can differentiate into tissue-specific cells in response to stimuli 
provided by different organs (Jiang et al., 2002). Sasaki et al. (2008) demonstrated that MSCs 
could differentiate into multiple skin cell types including keratinocytes and contribute to 
wound repair. Currently, in equine medicine there is not an ideal source of stem cells and a 
standard protocol for the application; however, most of the research focuses on MSCs derived 
from adult tissue, as bone marrow, adipose tissue and peripheral blood (Adams et al., 2013; 
Burk et al., 2013; Radtke et al., 2013; Spaas et al., 2013; Carter-Arnold et al., 2014; Ferris et 
al. 2014; Lopez and Jarazo, 2014; Burk et al, 2016). The adult tissue provides autologous 
cells, whereas to use autologous cells from foetal adnexa they need to be collected at birth and 
cryopreserved. 
Carrade et al. (2011) evaluated the hypersensitivity response to intradermal injections of 
autologous and allogenic MSCs derived from umbilical cord tissue (UCT). MSC injection 
resulted in minor wheal formation, characterized by mild dermatitis, dermal edema and 
endothelial hyperplasia, that fully resolved by 48 – 72 h. They concluded that equine 
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allogeneic UCT MSC might be safely administered intradermal without stimulating a 
measurable cellular immune response. 
Azari et al. (2011) evaluated the effects of intradermal injections of caprine WJ-MSCs on first 
intention cutaneous wound healing in healthy goats. This study demonstrated the beneficial 
effect of injections of caprine WJ-MSCs on wounds surgically made. The histopathological 
and microscopic evaluation revealed that re-epithelialization was complete at days 7 and less 
inflammation, thinner granulation tissue formation with minimum scar in the treated wounds 
in comparison with control wounds (Azari et al., 2011). The umbilical cord, since it is a 
discarded material after delivery, represents an excellent alternative non-invasive source of 
MSCs. Moreover, WJ-MSCs are highly proliferative, show tri-lineage differentiation ability 
and may have broader differentiation capacity than BM-MSCs (Carrade et al., 2011). 
Additionally, human WJ-MSCs have potent immunosuppressive properties including the 
reduction of lymphocyte proliferation in vitro (Li et al., 2007; Weiss et al., 2008). 
Our research group performed two studies about the wound healing with cutaneous 
application of Amniotic Fluid MSCs (Iacono et al., 2012b; Iacono et al., 2016). In the first 
paper, heterologous AF-MSCs were applied with platelet rich plasma (PRP) on a sore 
localized at right hock in a septic neonatal foal. The regression of wound healing was 
compared with other treatment applied on other sores in the same foal. The mean regression 
rate of MSCs + PRP (26.1%) was statistically higher than the others (20.6% and 18.1% Aloe 
gel, 18.1% PRP; Iacono et al., 2012b). In the more recent paper, heterologous AF-MSCs were 
applied in a carboxymethylcellulose (CMC) gel on spontaneously arisen pressure sores in 
seven hospitalized neonatal foals. As control, a commercial ointment was used. The mean 
regression rate with AF-MSCs in CMC gel was statistically higher than the mean value 
recorded in the control group, associated with a significant effect of the treatment used and a 
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statistically significant effect of treatment over time (Iacono et al., 2016). The results 
suggested that local application of MSCs isolated from amniotic fluid, using CMC as 
scaffold, could be considered as an effective treatment of deep sores in hospitalized neonatal 
foals (Iacono et al., 2016). In the present study, the size of the sore was reduced by 74%. We 
obtained this higher rate in comparison with Iacono et al. (2016) results probably because of 
the previous wound bed preparation. In addition, the 6 months old filly was healthy, unlike 
other foals that had continuous pressure stimulus on the wounds, so the healing process was 
slower. 
The gel containing MSCs adheres well to the wound and acts as a dressing. Instead, 
intradermal injections resulted to be painful, and therefore required appropriate restraint of the 
animal and good sedation with detomidine and butorphanol; furthermore, it is itself an 
inflammatory stimulus. In our case, in fact, cutaneous application did not require any sedation 
of the animal, and it was necessary just a minimum restraint to carry out the bandage. 
In the last phase, the treatment of the sore was carried out with an ointment containing ozone 
and the size of the sore was reduced by 80%. Bactericidal and pro-oxidant properties of ozone 
therapy on wound healing is well documented (Sagai and Bocci, 2011; degli Agosti et al., 
2016). Recently, in human medicine, Rosul and Patskan (2016) reported that superficial and 
deep ulcers in 47 diabetic patients treated with ozone healed more rapidly than in control 
group. Ozone promotes the improvement of lipid peroxidation and antioxidant protection, and 
reduces the time of hospitalization (Rosul and Patskan, 2016). Furthermore, the ozone therapy 
activates the proliferation of fibroblasts by releasing oxygen and promotes the production of 
intercellular matrix with consequent proliferation of keratinoblasts and successive complete 
wound healing (Travagli et al., 2010). The use of cutaneous application of ozone in our case 
contributed to maintain vital the granulation tissue until the complete healing of the sore. 
S E C T I O N  I I I -    C l i n i c a l  A p p l i c a t i o n | 161 
 
Unfortunately, it was not possible to perform a biopsy after the 3 phases of treatment, given 
the concern of the owner about a possible re-injury of the skin. 
In conclusion, the most important step in wound healing is the accurate assessment of the 
wound to avoid an erroneous therapy. It is also important to evaluate the macroscopic changes 
of the wound and to choose a proper therapy. Since the absence of side effects and the good 
results obtained, the local use of heterologous MSCs derived from Wharton’s jelly could 
represent a perfect healing treatment on deep wounds also in adult horses.
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GENERAL RESULTS AND DISCUSSION 
The purpose of this PhD thesis was to perform a dissertation about the equine umbilical cord 
(UC), with particular attention to its macroscopic characteristics moving into its microscopic 
features, since UC is a good Mesenchymal Stem Cells (MSCs) niche. 
The first section aimed to describe the macroscopic features of equine UC (length and number 
of coils), to calculate the umbilical coiling index (UCI) in normal pregnancy and healthy foals 
of three different breeds. One hundred twenty four healthy mares with normal pregnancy were 
enrolled in the study and were divided into three groups according to the breed: 70 
Standardbreds (STB), 38 Thoroughbreds (THB) and 16 Saddlebreds (SAD). All the STB and 
SAD were housed in Italy while the THB were housed in New Zealand. Mare’s age was 
higher in SAD than in THB and STB; the latter had a significantly lower gestational length. 
The foal’s weight was positively correlated with placental weight in all breeds; in STB, the 
foal’s weight was positively related to parity and gestational length. Regarding the mean total 
UC length, data reported in the present study are comparable to the previous reported in 
Thoroughbred, Standardbred and Warmblood. The length of the two UC portions was 
statistically different between STB and THB, where the amniotic portion is longer than the 
allantoic one. In each breed, total UC length was correlated with number of total coils (THB 
and STB = 5±1; SAD = 6±1), the UC’s amniotic length was positively correlated with the 
number of amniotic coils as the allantoic length with the number of allantoic coils. The 
normal UCI was 0.09 in STB and THB and 0.1 in SAD. The number of coils and the UCI has 
never been investigated in veterinary medicine.  
The first section aimed also to microscopically and immunohistochemically describe the 
physiological aspects of equine umbilical cord. Twenty-eight healthy mares housed for 
attended delivery were enrolled in the study. Immediately after breaking of the umbilical cord, 
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the intramniotic portion closest to the foal (about 15 cm) was collected. The following data 
were recorded: gestational length, days of pregnancy, length of stage II labour (minutes), 
placental weight and presence of foetal membranes alterations. Macroscopic evaluation of 
umbilical cords was performed for evaluating WJ’s distribution. Furthermore, immediately 
after foaling, APGAR score, foal’s weight, sex and outcome were recorded. Umbilical cord’s 
sections were stained with Masson’s trichrome stain, Orcein technique to identify elastic 
fibres and with Silver Impregnation technique to identify reticular fibres. The 
immunohistochemical analysis was conducted giving particular attention at WJ. The WJ was 
found just in the intramniotic portion of UC, closest to the foal, while it was absent in the 
allantoic portion. The amount of WJ (g), mean 5.1 ± 3.2, was negatively correlated with the 
mare’s age (P< 0.05; r= - 0.387). All the vessels (two umbilical arteries and one umbilical 
vein) showed the three typical layers: tunica intima, tunica media and tunica adventitia. A 
perivascular tissue, composed by dense collagen fibres arranged concentrically, surrounded 
the tunica adventitia. Wharton’s jelly was made of collagen fibres, which were arranged to 
create a loose reticular texture with also fibroblast, white blood cells and capillaries. Finally, 
the UC were externally surrounded by amniotic membrane. Elastic fibres were less 
concentrated with an uneven pattern around the vessels and a dense network of reticular fibres 
was found in the entire section of the cord. The immunohistochemical analysis revealed the 
presence of fibroblast cells positive for antibodies anti-type I, V and VI collagen and anti-
fibrillin. For the first time in equine medicine, we reported the physiological amount of 
Wharton’s jelly in normal umbilical cord. In human medicine, in fact, a quantitative variation 
of WJ was associated with pathological conditions such as hypertensive disorders, foetal 
distress, gestational diabetes and foetal growth restriction. Furthermore, the total absence of 
WJ has been associated with foetal death. The reduction of WJ facilitate torsion, compression 
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or stretching of UC that would adversely affect foetal blood flow. Given the presence in 
human species of a strong correlation between these and specific pathological conditions of 
newborn and mother, further studies are needed, both on normal and high risk pregnancies to 
verify the presence of these correlations also in the equine species. 
In the second and major component of this dissertation, the ultrastructural characterization 
and immune profile of equine MSCs derived from foetal tissues (Wharton’s jelly and blood) 
were investigated; equine foetal MSCs were then compared to human foetal MSCs and equine 
adult MSCs. 
In the first study we compared clinically relevant characteristics of equine MSCs derived 
from AM and WJ; we found that MSCs were more easily isolated from WJ, even if MSCs 
derived from AM exhibited most rapid proliferation (P<0.05). Osteogenic and chondrogenic 
differentiation was most prominent in MSCs derived from WJ, as also suggested by the lower 
adhesion of AM cells, demonstrated by the greater volume of spheroids after hanging drop 
culture (P<0.05). Data obtained by PCR confirmed the immunosuppressive function of AM 
and WJ-MSCs and the presence of active genes specific for anti-inflammatory and angiogenic 
factors (IL-6, IL 8, IL-β1). For the first time, by means of transmission electron microscopy 
(TEM), we ascertained that equine WJ-MSCs constitutively produce a very impressive 
number of large vacuolar bodies, scattered throughout the cytoplasm. Through the 
examination of cell monolayers by TEM, we observed that the most noteworthy difference 
between AM-MSCs and WJ-MSCs was the presence of an abundant extracellular fibrillar 
matrix located in the intercellular spaces among WJ-MSCs. These findings indicate that 
MSCs from different sources display significantly different properties that may impact on 
their therapeutic application. The data presented in this paper have an additional value, as they 
can be noteworthy for horses as well as for other mammalian species, including humans. 
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The second study of this section aimed to compare human and equine WJ-MSCs. Human and 
equine WJ-MSCs were isolated and cultured using the same protocols and culture media. 
Cells were characterized by analysing morphology, growth rate, migration and adhesion 
capability, immunophenotype, differentiation potential and ultrastructure. Results showed that 
human and equine WJ-MSCs have similar ultrastructural details connected with intense 
synthetic and metabolic activity, but differ in growth, migration, adhesion capability and 
differentiation potential. In fact, at the scratch assay, the migration rate of human WJ-MSCs 
was higher (P<0.05) than that of equine cells, while the volume of spheroids obtained after 48 
h of culture in hanging drop was larger than the volume of equine ones (P<0.05), 
demonstrating a lower cell adhesion ability. This also revealed the lower doubling time of 
equine cells (3.5 ± 2.4) as compared to human (6.5 ± 4.3) (P<0.05), and subsequently the 
higher number of cell doubling after 44 days of culture observed for the equine (20.3 ± 1.7) as 
compared to human cells (8.7 ±2.4) (P<0.05). Even if in both species tri-lineage 
differentiation was achieved, equine cells showed a higher chondrogenic and osteogenic 
differentiation ability (P<0.05). Our findings indicate that, although the ultrastructure 
demonstrated a staminal phenotype in human and equine WJ-MSCs, they showed different 
properties reflecting the different sources of MSCs. 
The third study of this section aimed of the study was to compare and describe property and 
characteristics of equine foetal and adult MSCs; in particular, MSCs derived from umbilical 
cord blood and Wharton’s jelly, bone marrow (BM) and adipose tissue (AT). Umbilical cord 
blood (UCB) and Wharton’s jelly (WJ) samples were collected immediately after delivery 
from three healthy mares. BM and AT were collected from three healthy horses. WJ-MSCs 
showed the highest chondrogenic and osteogenic differentiation potential, related to UCB-
MSCs and adult cells. On the contrary, cells isolated from fluid matrix (BM and UCB) 
G e n e r a l  R e s u l t s  a n d  D i s c u s s i o n  | 171 
 
showed a higher ability to differentiate in tenocytes, while WJ-MSCs showed the lower one. 
ICC investigation showed in all the cells a positive expression of the mesodermal marker 
alpha-SMA. However, the ICC results regarding the expression of N-Cadherin by cells but 
derived from fluid matrix (UCB and BM) are controversial. WJ-MSCs were the unique that 
expressed OCT-4, IL-8, IL-β1 and IL-6. Their expression by WJ-MSCs make these cells the 
best choice for the application in regenerative medicine, also for the non-invasive collection 
of WJ because umbilical cord is routinely discarded at parturition. In this study, numerous 
intra and extracellular vacuolar bodies in foetal MSCs and only extracellular vescicles in adult 
MSCs were found. These vesicles, originated from the internal layer of the cell membrane, 
had different dimensions (small, medium and big), containing a material of unknown 
composition. As demonstrated by other authors, they have the role of collecting efficiently 
cellular components: since cells have an intense replicative and metabolic capacity, they 
continuously need a renovation of their structures. Recent studies support the idea that these 
microvesicles contain some substances, made by the cell itself, that have a fundamental role 
in stimulating healing processes in damaged tissues (Du et al., 2014; Lange-Consiglio et al., 
2016), and have also immunomodulatory activities 
The third section included the clinical applications of MSCs derived from AF and WJ on 
cutaneous wounds of different ages’ foals. The employ of foetal MSCs on cutaneous wounds 
decreased their healing both in neonatal foals and six-month foals, in comparison with other 
traditional treatments.  
In the first study of this section, an innovative therapy for spontaneously arisen pressure sores 
in seven hospitalized neonatal foals is described, using amniotic fluid Mesenchymal Stem 
Cells (AF-MSCs). Cells were isolated from amniotic fluid collected at delivery in healthy 
mares. Heterologous cells, at passage three of in vitro culture, were local applied to sores 
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twice a week for four consecutive times in a carboxymethylcellulose (CMC) gel. As a control, 
a commercial ointment was used. The results showed that the mean sore regression rate with 
AF-MSCs in CMC gel was statistically higher than the mean value recorded in the control 
group. This was associated with a significant effect of the treatment used and a statistically 
significant effect of treatment over time.  
In the second study of this section, a 6 months old filly, with a skin wound on the left hock, 
was treated with WJ-MSCs and the wound’s regression was determined. The treatment was 
divided into three phases: surgical, regenerative and medical. In order to monitor daily the 
healing, the wound was evaluated macroscopically following two human classifications. In 
the surgical phase two surgical curettages were carried out and then the wound was daily 
treated with commercial cream. In the regenerative phase of the treatment, lasted 18 days, we 
performed four cutaneous applications of heterologous WJ-MSCs in carboxymethyl cellulose 
gel, as a scaffold and autologous plasma, as metabolic support for the cells. After the first 
application, the vital granulation tissue that filled the wound was already visible and the 
disappearance of the small amount of necrotic tissue that was present at the end of the surgical 
phase was evident. In the medical phase the wound was daily cleaned and treated with ozone 
bases ointment. The three phases of the treatment led to a progressive reduction of wound’s 
dimension: 7.28±0.20 cm
2 
at the end of the first phase, 1.90±0.03 cm
2
 after the WJ-MSCs 
application and 0.38±0.01 cm
2
 at discharge. 
Since the absence of side effects and the good results obtained, the local use of heterologous 
MSCs derived from foetal adnexa could represent a perfect healing treatment on deep wounds 
both in hospitalized neonatal foals and adult horses. 
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CONCLUSIONS 
Based on our results, it is evident that the umbilical cord, usually discarded, warrants major 
attention in equine medicine: both for the evaluation of the foal at birth and as optimal source 
of Mesenchymal Stem Cells. 
The results obtained in these studies on healthy foal’s umbilical cord could be useful as 
control in further studies to evaluate if any alteration could be related to neonatal illness, as in 
human medicine. 
We also underlined differences and similarities between equine and human fetal MSCs, and 
equine adult and fetal MSCs; finally, we applied the fetal MSCs on spontaneous wounds in 
foals and we obtained a very high regression rate without any side effects. 
